<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury - Jones, P - 2020 | Cochrane Library</title> <meta content="Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury - Jones, P - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007789.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury - Jones, P - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007789.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007789.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury" name="citation_title"/> <meta content="Peter Jones" name="citation_author"/> <meta content="Auckland City Hospital" name="citation_author_institution"/> <meta content="peterj@adhb.govt.nz" name="citation_author_email"/> <meta content="Rain Lamdin" name="citation_author"/> <meta content="Auckland City Hospital" name="citation_author_institution"/> <meta content="Stuart R Dalziel" name="citation_author"/> <meta content="The University of Auckland" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD007789.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/08/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007789.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007789.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007789.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Acetaminophen [administration &amp; dosage, adverse effects]; Acute Disease; Administration, Oral; Analgesics [*administration &amp; dosage, adverse effects]; Analgesics, Opioid [administration &amp; dosage, adverse effects]; Anti-Inflammatory Agents, Non-Steroidal [*administration &amp; dosage, adverse effects]; Bias; Contusions [*drug therapy]; Pain [drug therapy]; Randomized Controlled Trials as Topic; Soft Tissue Injuries [*drug therapy]; Sprains and Strains [*drug therapy]; Time-to-Treatment" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007789.pub3&amp;doi=10.1002/14651858.CD007789.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="eLIOL3Be";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007789\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007789\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","th","ko","ms","hr","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007789.pub3",title:"Oral non\\u2010steroidal anti\\u2010inflammatory drugs versus other oral analgesic agents for acute soft tissue injury",firstPublishedDate:"Aug 12, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Bone, Joint and Muscle Trauma Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007789.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007789.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007789.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007789.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007789.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007789.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007789.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007789.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007789.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007789.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13886 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007789.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-sec-0121"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-sec-0106"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/appendices#CD007789-sec-0126"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/table_n/CD007789StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/table_n/CD007789StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information#CD007789-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Peter Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information#CD007789-cr-0005">Rain Lamdin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information#CD007789-cr-0006">Stuart R Dalziel</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information/en#CD007789-sec-0158">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 August 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007789.pub3">https://doi.org/10.1002/14651858.CD007789.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007789-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007789-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007789-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007789-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007789-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007789-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD007789-abs-0003">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD007789-abs-0005">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007789-abs-0001" lang="en"> <section id="CD007789-sec-0001"> <h3 class="title" id="CD007789-sec-0001">Background</h3> <p>Acute soft tissue injuries are common and costly. The best drug treatment for such injuries is not certain, although non‐steroidal anti‐inflammatory drugs (NSAIDs) are often recommended. There is concern about the use of oral opioids for acute pain leading to dependence. This is an update of a Cochrane Review published in 2015. </p> </section> <section id="CD007789-sec-0002"> <h3 class="title" id="CD007789-sec-0002">Objectives</h3> <p>To assess the benefits or harms of NSAIDs compared with other oral analgesics for treating acute soft tissue injuries. </p> </section> <section id="CD007789-sec-0003"> <h3 class="title" id="CD007789-sec-0003">Search methods</h3> <p>We searched the CENTRAL, 2020 Issue 1, MEDLINE (from 1946), and Embase (from 1980) to January 2020; other databases were searched to February 2019. </p> </section> <section id="CD007789-sec-0004"> <h3 class="title" id="CD007789-sec-0004">Selection criteria</h3> <p>We included randomised or quasi‐randomised controlled trials involving people with acute soft tissue injury (sprain, strain, or contusion of a joint, ligament, tendon, or muscle occurring within 48 hours of inclusion in the study), and comparing oral NSAIDs versus paracetamol (acetaminophen), opioid, paracetamol plus opioid, or complementary and alternative medicine. The outcomes were pain, swelling, function, adverse effects, and early re‐injury. </p> </section> <section id="CD007789-sec-0005"> <h3 class="title" id="CD007789-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed studies for eligibility, extracted data, and assessed risk of bias. We assessed the quality of the evidence using GRADE methodology. </p> </section> <section id="CD007789-sec-0006"> <h3 class="title" id="CD007789-sec-0006">Main results</h3> <p>We included 20 studies, with 3305 participants. Three studies included children only. The others included predominantly young adults; approximately 60% were male. Seven studies recruited people with ankle sprains only. Most studies were at low or unclear risk of bias; however, two were at high risk of selection bias, three were at high risk of bias from lack of blinding, and five were at high risk of selective outcome reporting bias. Some evidence relating to pain relief was high certainty. Other evidence was either moderate, low or very low certainty, reflecting study limitations, indirectness, imprecision, or combinations of these. Thus, we are certain or moderately certain about some of the estimates, and uncertain or very uncertain of others. </p> <p>Eleven studies, involving 1853 participants compared NSAIDs with paracetamol. There were no differences between the two groups in pain at one to two hours (1178 participants, 6 studies; high‐certainty evidence), at days one to three (1232 participants, 6 studies; high‐certainty evidence), and at day seven or later (467 participants, 4 studies; low‐certainty evidence). There was little difference between the groups in numbers of participants with minimal swelling at day seven or later (77 participants, 1 study; low‐certainty evidence). Very low‐certainty evidence from three studies (386 participants) means we are uncertain of the finding of little difference between the two groups in return to function at day seven or later. There was low‐certainty evidence from 10 studies (1504 participants) that NSAIDs may slightly increase the risk of gastrointestinal adverse events compared with paracetamol. There was low‐certainty evidence from nine studies (1679 participants) of little difference in neurological adverse events between the NSAID and paracetamol groups. </p> <p>Six studies, involving 1212 participants compared NSAIDs with opioids. There was moderate‐certainty evidence of no difference between the groups in pain at one hour (1058 participants, 4 studies), and low‐certainty evidence for no difference in pain at days four or seven (706 participants, 1 study). There was very low‐certainty evidence of no important difference between the groups in swelling (84 participants, 1 study). Participants in the NSAIDs group were more likely to return to function in 7 to 10 days (542 participants, 2 studies; low‐certainty evidence). There was moderate‐certainty evidence (1143 participants, 5 studies) that NSAIDs were less likely to result in gastrointestinal or neurological adverse events compared with opioids. </p> <p>Four studies, involving 240 participants, compared NSAIDs with the combination of paracetamol and an opioid. The applicability of findings from these studies is in question because the dextropropoxyphene combination analgesic agents used are no longer in general use. Very low‐certainty evidence means we are uncertain of the findings of no differences between the two interventions in the numbers with little or no pain at day one (51 participants, 1 study), day three (149 participants, 2 studies), or day seven (138 participants, 2 studies); swelling (230 participants, 3 studies); return to function at day seven (89 participants, 1 study); and the risk of gastrointestinal or neurological adverse events (141 participants, 3 studies). </p> <p>No studies reported re‐injury rates.</p> <p>No studies compared NSAIDs with oral complementary and alternative medicines,</p> </section> <section id="CD007789-sec-0007"> <h3 class="title" id="CD007789-sec-0007">Authors' conclusions</h3> <p>Compared with paracetamol, NSAIDs make no difference to pain at one to two hours and at two to three days, and may make no difference at day seven or beyond. NSAIDs may result in a small increase in gastrointestinal adverse events and may make no difference in neurological adverse events compared with paracetamol. </p> <p>Compared with opioids, NSAIDs probably make no difference to pain at one hour, and may make no difference at days four or seven. NSAIDs probably result in fewer gastrointestinal and neurological adverse effects compared with opioids. </p> <p>The very low‐certainly evidence for all outcomes for the NSAIDs versus paracetamol with opioid combination analgesics means we are uncertain of the findings of no differences in pain or adverse effects. </p> <p>The current evidence should not be extrapolated to adults older than 65 years, as this group was not well represented in the studies </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007789-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007789-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007789-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007789-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007789-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007789-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007789-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007789-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD007789-abs-0004">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD007789-abs-0006">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007789-abs-0002" lang="en"> <h3>Oral non‐steroidal anti‐inflammatory drugs compared with other oral pain killers for sprains, strains and bruises </h3> <p><b>Introduction and aims</b> </p> <p>Sprains, strains, and bruises are common injuries, and people with these injuries often require pain relief, given as a tablet or capsule that is swallowed (oral). Many types of oral painkillers are available to treat such injuries. We wanted to know whether there were any differences in people's pain, swelling, function, or unwanted side effects when sprains, strains, and bruises were treated with oral non‐steroidal anti‐inflammatory drugs (NSAIDs, e.g. ibuprofen) compared with paracetamol, opioids (e.g. codeine), complementary or alternative medicines, or combinations of these. </p> <p>This is an update of a Cochrane review published in 2015.</p> <p><b>What did we do?</b> </p> <p>We searched medical databases up to January 2020 for studies that compared NSAIDs with other painkillers in people with sprains, strains, and bruises. Study participants could be any age. We assessed the included studies to judge the reliability (certainty) of the evidence. We categorised the evidence as being of high, moderate, low, or very low certainty. High certainty means we are confident in the evidence, moderate certainty means we are fairly confident, low or very low certainty means that we are unsure or very unsure of the reliability of the evidence. </p> <p><b>Results of our search and description of studies</b> </p> <p>We included 20 studies, with 3305 participants. Seven studies included people with ankle sprain only. Three studies included children only. Most of the participants of the other studies were young adults, and there were slightly more men than women. Few participants were aged over 65 years. Eleven studies compared NSAIDs with paracetamol, six studies compared NSAIDs with opioids, and four studies compared NSAIDs with paracetamol combined with an opioid. Studies reported outcomes at times varying from one hour after taking the medication, up to 10 to 14 days. </p> <p><b>Main results</b> </p> <p>There is no difference between NSAIDs and paracetamol in pain after one to two hours, or after two to three days (high‐certainty evidence), and there may be no difference after a week or more (low‐certainty evidence). There is low‐certainty evidence that NSAIDs may make little difference to swelling after a week or more. We are uncertain whether NSAIDs make a difference to return to function after a week or more (very low‐certainty evidence). There is low‐certainly evidence that NSAIDs may slightly increase unwanted side effects related to the gut. </p> <p>There is probably no difference between NSAIDs and opioids in pain at one hour (moderate‐certainly evidence), and there may be no difference four or seven days after taking medication (low‐certainty evidence). We are uncertain whether NSAIDs make a difference to swelling after 10 days (very low‐certainty evidence). There is low‐certainty evidence that NSAIDs may increase return to function in 7 to 10 days. There is moderate‐certainty evidence that NSAIDs probably result in fewer unwanted side effects, such as nausea and dizziness, compared with opioids. </p> <p>The evidence suggests that there is little or no difference between NSAIDs and paracetamol combined with opioids in pain, swelling, return to function, or unwanted side effects. However, the evidence was very low certainty, so we are uncertain of these results. </p> <p>No studies reported the risk of re‐injury after treatment.</p> <p>We found no studies comparing NSAIDs with complementary or alternative medicines.</p> <p><b>Conclusions</b> </p> <p>The body of evidence to date has found no difference between NSAIDs and other pain killers for pain relief for strains, sprains, and bruises in younger people. However, we need more, and better evidence on return to function and unwanted side effects in all age groups, particularly in older people. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007789-sec-0121" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007789-sec-0121"></div> <h3 class="title" id="CD007789-sec-0122">Implications for practice</h3> <section id="CD007789-sec-0122"> <p>Compared with paracetamol, NSAIDs make no difference to pain at one to two hours and at two to three days (high‐certainty evidence) and may make no difference at day seven or beyond (low‐certainty evidence). There is low‐certainty evidence that NSAIDs may make little difference to swelling after a week or more. We are uncertain whether NSAIDs make a difference to return to function at a week or over (very low‐certainty evidence). There is low‐certainly evidence that NSAIDs may result in a small increase in gastrointestinal adverse events and may make no difference in neurological adverse events compared with paracetamol. </p> <p>Compared with opioids, NSAIDs probably make no difference to pain at one hour (moderate‐certainly evidence) and may make no difference at days four or seven (low‐certainty evidence). We are uncertain whether NSAIDs make a difference to swelling at 10 days (very low‐certainty evidence). There is low‐certainty evidence that NSAIDs may increase return to function at 7 to 10 days follow‐up. There is moderate‐certainty evidence that NSAIDs probably result in fewer gastrointestinal and neurological adverse effects compared with opioids. </p> <p>There was very low‐certainty evidence for all outcomes for the NSAIDs versus paracetamol with opioid combination analgesics comparison. Thus we are uncertain of the findings of no between‐groups differences in pain, swelling, return to function or adverse effects. </p> <p>The current evidence should not be extrapolated to adults older than 65 years, as this group was not well represented in the studies. </p> </section> <h3 class="title" id="CD007789-sec-0123">Implications for research</h3> <section id="CD007789-sec-0123"> <p>Further studies of analgesic efficacy between oral analgesics currently used for acute soft tissue injury in young adults are not a priority; none of the evidence thus far has shown a discernable difference between any of them for the outcome of pain. However, this review raises other questions. The evidence regarding return to function remains incomplete, while the evidence of more gastrointestinal adverse effects with NSAID compared with paracetamol is low certainty and there were no studies of COX‐2 specific NSAID compared with paracetamol. These should be the primary outcome of future research around pharmacological interventions for acute soft tissue injuries. Further research is also warranted in older people with these injuries, again with a focus on functional benefit and adverse effects. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007789-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007789-sec-0008"></div> <div class="table" id="CD007789-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">NSAID compared with paracetamol for acute soft tissue injury</span></div> <tbody> <tr class="separated"> <th align="left" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>NSAID compared with paracetamol for acute soft tissue injury</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute soft tissue injury, such as ankle sprain<br/><b>Setting:</b> various outpatient locations (e.g. emergency department, student health centre)<br/><b>Intervention:</b> NSAID<br/><b>Comparison:</b> paracetamol </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with paracetamol</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NSAIDs</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 1 to 2 hours</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across paracetamol groups from 43 to 55 mm; and ‐12 to ‐19 mm mean reduction from baseline </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the NSAID groups was 0.12 mm lower<br/>(2.27 lower to 2.03 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1178<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies included mixed STI populations.</p> <p>The confidence interval did not reach the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at days 1 to 3 (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 2 to 3 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across paracetamol groups from 11.9 to 36.7 mm; and ‐12.7 to ‐18.3 mm mean reduction from baseline </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the NSAID groups was 1.5 mm higher<br/>(0.91 lower to 3.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1232<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies included ankle sprains and four included mixed STI populations.</p> <p>The confidence interval did not reach the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain on day 7 or later (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 7 to 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across control groups from 5.0 to 6.3 mm; with ‐54.4 mm mean reduction from baseline </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the NSAID groups was 1.55 mm higher<br/>(0.33 lower to 3.43 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>467<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All four studies included ankle sprains; one included only children.</p> <p>The confidence interval did not reach the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no swelling on day 7 or later</b> </p> <p><i>Follow‐up: 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/>(0.58 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The study included children with ankle sprains only.</p> <p>This lack of difference was also found by two more studies (290 participants) involving ankle sprains that presented continuous (volume and VAS) data </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>639 per 1000<sup>c</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>537 per 1000<br/>(371 to 779) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Return to function on day 7 or later</b><sup>e</sup> </p> <p><i>Follow‐up: 9 to 14 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/>(0.90 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>386<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Two studies included ankle sprains; one included children only, and one included a mixed STI population. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>820 per 1000<sup>f</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>812 per 1000<br/>(738 to 894) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Gastrointestinal adverse events</b> </p> <p><i>Follow‐up: 1 hour to 30 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.34<br/>(0.97 to 1.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1504<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>i</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies included ankle sprains, one included children only, and six included mixed STI populations. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000<sup>h</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>101 per 1000<br/>(73 to 140) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurological adverse events</b><br/><i>Follow‐up: 1 hour to 30 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/>(0.62 to 1.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1679<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>j</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies included ankle sprains, one included children only, and five included mixed STI populations. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000<sup>h</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/>(57 to 108) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Early re‐injury</b> (within 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MCID:</b> minimal clinically important difference; <b>RR:</b> risk ratio; <b>STI:</b> soft tissue injury </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty.</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty.</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty.</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty.</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> One study (100 participants) at unclear risk of bias across all domains slightly favoured paracetamol, while five others at low risk of bias did not. The evidence was not downgraded for risk of bias or inconsistency as including this study did not impact the finding of no statistically significant or clinically important difference<br/><sup>b</sup> We downgraded the evidence by one level for study limitations (three studies were at unclear risk of several biases, including selection bias), and one level for indirectness reflecting suboptimal dosing of paracetamol in two studies (although these favoured paracetamol), and of both comparators in one study. Although there was inconsistency, reflecting statistically significant heterogeneity (P = 0.04; I² = 63%) of the pooled results, we did not consider this a reason to further downgrade the evidence, given the lack of clinical significance of the individual results of these studies<br/><sup>c</sup> Assumed risk = control group risk in the study reporting this outcome<br/><sup>d</sup> We downgraded the evidence by one level for study limitations (the sole study reporting this outcome was at unclear risk of bias relating to incomplete data for this outcome), and one level for imprecision (wide confidence intervals)<br/><sup>e</sup> Function assessed differently in each study: numbers with no disability at day 14; numbers resuming sporting activity at day 10; and numbers who had resumed normal activity at day 9<br/><sup>f</sup> Assumed risk = median control group risk in the studies reporting this outcome<br/><sup>g</sup> We downgraded the evidence by two levels for study limitations (one study was at high risk of selection bias and one at high risk of reporting bias), and one level for imprecision. Of note is the suboptimal dosing of paracetamol in one study, and of both comparators in another study.<br/><sup>h</sup> Assumed risk = average risk for those in the paracetamol groups<br/><sup>i</sup> We downgraded the evidence two levels for imprecision, as the lower confidence level just passed the point of no difference and the upper confidence level indicates an important difference<br/><sup>j</sup> We downgraded the evidence two levels for imprecision, as the confidence interval was wide and included both benefit and harm </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007789-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAID compared with opioid for acute soft tissue injury</span></div> <tbody> <tr class="separated"> <th align="left" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>NSAID compared with opioid for acute soft tissue injury</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute soft tissue injury<br/><b>Setting:</b> various outpatient locations (e.g. emergency department, sports club)<br/><b>Intervention:</b> NSAID<br/><b>Comparison:</b> opioid </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with opioid</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NSAID</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 1 hour</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across opioid groups from 13 to 27.7 mm</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the NSAID group was 0.49 mm lower<br/>(3.05 lower to 2.07 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1058<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Three studies included a mixed STI population, one in children; the other study involved ankle sprains. </p> <p>The confidence interval did not include the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at days 4 to 6 (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 4 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the opioid group was 31.8 mm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the NSAID group was<br/>2.9 mm lower (6.06 lower to 0.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no data for the earlier interim period (up to 3 days).</p> <p>The study included ankle sprains.</p> <p>The confidence interval did not include the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain on day 7 or later (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the opioid group was 15.1 mm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the NSAID group was 6.5 mm lower<br/>(9.31 lower to 3.69 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study included ankle sprains.</p> <p>The confidence interval did not include the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no swelling on day 7 or later</b> </p> <p><i>Follow‐up: 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.14<br/>(0.61 to 2.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>84<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The study included ankle sprains</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000<sup>c</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1000<br/>(183 to 639) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Return to function on day 7 or later</b> </p> <p><i>(numbers returning to full function or returning to training)</i> </p> <p><i>Follow‐up: 7 to 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/>(1.03 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>749<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study included ankle sprains, and one a mixed STI population.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>664 per 1000<sup>e</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>750 per 1000<br/>(684 to 830) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Gastrointestinal adverse events</b> </p> <p><i>Follow‐up: 2 hours to 14 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.48<br/>(0.36 to 0.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1151<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies included a mixed STI population, one in children; the other study involved ankle sprains. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>205 per 1000<sup>e</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>98 per 1000<br/>(74 to 127) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurological adverse events</b> </p> <p><i>Follow‐up: 2 hours to 14 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/>(0.30 to 0.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1151<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies involved a mixed STI population, one in children; the other study involved ankle sprains. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<sup>e</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 per 1000<br/>(61 to 108) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Early re‐injury</b> (with 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See Comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MCID:</b> minimal clinically important difference; <b>RR:</b> risk ratio; <b>STI:</b> soft tissue injury </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty.</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty.</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty.</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty.</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> We downgraded the evidence one level for indirectness, 49% of the evidence and 67% of participants came from one study that used a COX‐2 selective NSAID that has been withdrawn from the market (Valdecoxib)<br/><sup>b</sup> We downgraded the evidence two levels for indirectness, The evidence came from one study that used a COX‐2 selective NSAID that has been withdrawn from the market (Valdecoxib), and also used a suboptimal dose of opioid as a comparator<br/><sup>c</sup> Assumed risk = control risk in this study<br/><sup>d</sup> We downgraded the evidence by two levels for severe study limitations (the sole study reporting this outcome was at high risk of attrition bias relating to incomplete data for this outcome), and one level for imprecision (wide confidence interval)<br/><sup>e</sup>Assumed risk = average control group risk in the studies reporting this outcome<br/><sup>f</sup> We downgraded the evidence one level for indirectness, more than 80% of the evidence and 61% of participants came from one study that used a COX‐2 selective NSAID that has been withdrawn from the market (Valdecoxib) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007789-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">NSAID compared with combination (paracetamol and opioid) analgesic for acute soft tissue injury</span></div> <tbody> <tr class="separated"> <th align="left" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>NSAID compared with combination (paracetamol and opioid) analgesic for acute soft tissue injury</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute soft tissue injury, such as ankle sprain<br/><b>Setting:</b> various outpatient locations (e.g. emergency department, GP practice)<br/><b>Intervention:</b> NSAID<br/><b>Comparison:</b> combination (paracetamol plus opioid) analgesic </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with combination (paracetamol and opioid) analgesic</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NSAID</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Little or no pain at &lt; 24 hours</b> </p> <p><i>Follow‐up: first day</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See Comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study involved ankle or wrist sprain in adults. Just one trial participant, who was in the NSAID group, had little or no pain on the first day. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no pain at 1 to 3 days</b> </p> <p><i>Follow‐up: day 3</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.49<br/>(0.65 to 3.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>149<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study included mixed soft tissue injuries (mainly acute), and the other, ankle and wrist sprain, both in adults. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1000<br/>(70 to 368) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no pain on day 7 or later</b> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/>(0.88 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>138<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study included mixed soft tissue injuries (mainly acute), and the other, ankle sprain, both in adults. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>671 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>705 per 1000<br/>(591 to 839) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Swelling on day 7 or later</b> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>All three studies presented the means of small categorical scales, so we were unable to present these results in quantitative meta‐analysis. Two (N = 132) reported no significant between‐group differences at three time points (days 3, 5, and 7). One study (N = 98) reported that there was no difference between groups for this outcome on day 7. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>230<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies included mixed soft tissue injuries, and one ankle sprain. All three were in adults. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Return to function on day 7 or later</b> </p> <p><i>Assessed as 'cure'</i> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28<br/>(0.90 to 1.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>89<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>This study included mixed soft tissue injuries in adults (76% acute)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>523 per 1000<sup>f</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>669 per 1000<br/>(470 to 946) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Gastrointestinal adverse events</b> </p> <p><i>Follow‐up: 3 to 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.21<br/>(0.03 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>141<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study involved ankle sprain, one study involved ankle and wrist sprain, and the third study, mixed soft tissue injuries, all in adults. </p> <p>Just 4 events were reported</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000<br/>(2 to 98) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurological adverse events</b> </p> <p><i>Follow‐up: 3 to 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.09 to 2.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>141<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study involved ankle sprain, one study involved ankle and wrist sprain, and the third study, mixed soft tissue injuries, all in adults. </p> <p>Just 4 events were reported</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/>(4 to 120) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Early re‐injury</b> (with 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See Comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MCID:</b> minimal clinically important difference; <b>RR:</b> risk ratio; <b>STI:</b> soft tissue injury </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty.</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty.</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty.</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty.</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> The available data (one participant experienced little or no pain) for this outcome are too limited to draw any conclusions or useful analysis. Nominally, we downgraded the evidence by one level for study limitations (unclear risk of selection bias and other bias), and two levels for imprecision (very few events, data from one small single study)<br/><sup>b</sup> Assumed risk = average risk for those in combination groups<br/><sup>c</sup> We downgraded the evidence by one level for study limitations (one study was at high risk of bias, reflecting lack of blinding of participants, and one was at unclear risk of selection bias, and other bias), one level for indirectness, since most of the weight of the evidence (87%) came from one study that had suboptimal dosing of both comparators, and two levels for imprecision (few events, wide confidence interval)<br/><sup>d</sup> We downgraded the evidence by one level for study limitations (one study was at high risk of bias, reflecting lack of blinding of participants, and one was at unclear risk of several biases), one level for indirectness, since most of the weight of the evidence (88%) came from one study that had suboptimal dosing of both comparators, and one level for imprecision (wide confidence interval)<br/><sup>e</sup> We downgraded the evidence two levels for risk of bias, as all three studies were either at high or unclear risk of bias across multiple domains, one level for indirectness, due to mixed study populations, and one level for imprecision, due to the small sample size<br/><sup>f</sup> Assumed risk = control group risk in the study reporting this outcome<br/><sup>g</sup> We downgraded the evidence by one level for study limitation (the study was at high risk of bias, relating to lack of participant blinding), two levels for indirectness, reflecting suboptimal dosing of comparators and the inadequate nature of the outcome, and one level for imprecision, due to the small sample size<br/><sup>h</sup> We downgraded the evidence by two levels for study limitations (two studies were at high risk of bias for one or more domains, and the other was at unclear risk of bias for several domains), and two levels for imprecision (very few events, wide confidence interval) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007789-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007789-sec-0009"></div> <section id="CD007789-sec-0010"> <h3 class="title" id="CD007789-sec-0010">Description of the condition</h3> <p>Acute soft tissue injuries are common; they cause 5% to 10% of emergency department attendances in the United Kingdom (<a href="./references#CD007789-bbs2-0121" title="HandollHH , GillespieWJ , GillespieLD , MadhokR . Moving towards evidence-based healthcare for musculoskeletal injuries: featuring the work of the Cochrane Bone, Joint and Muscle Trauma Group. Journal of the Royal Society for the Promotion of Health2007;127(4):168-73. [PMID: 17711062]">Handoll 2007</a>; <a href="./references#CD007789-bbs2-0197" title="WilliamsGJP , SperrynPN . Sports Medicine. 2nd edition. London: Edward Arnold, 1979.">Williams 1979</a>). In Australia, over five million sports injuries occur annually (<a href="./references#CD007789-bbs2-0094" title="CassellEP , FinchCF , StathakisVZ . Epidemiology of medically treated sport and active recreation injuries in the Latrobe Valley, Victoria, Australia. British Journal of Sports Medicine2003;37(5):405-9. [PMID: 14514530]">Cassell 2003</a>; <a href="./references#CD007789-bbs2-0154" title="Medibank Private. Safe sports report 2006. www.medibank.com.au/Client/Documents/Pdfs/Medi_Safe_Sports_Report_2006.pdf (accessed 31 July 2008).">Medibank 2006</a>), and in Germany, 3.1% of the population sustain a sports injury each year, most of which are acute soft tissue injuries (<a href="./references#CD007789-bbs2-0183" title="SchneiderS , SeitherB , TöngesS , SchmittH . Sports injuries: population based representative data on incidence, diagnosis, sequelae, and high risk groups. British Journal of Sports Medicine2006;40(4):334-9. [PMID: 16556789]">Schneider 2006</a>). </p> <p>The costs associated with these 'minor' injuries are substantial, with the lifetime cost of soft tissue injuries sustained in 2019 estimated at over $5 billion NZD in New Zealand (population: approximately five million; <a href="./references#CD007789-bbs2-0075" title="Accident Compensation Corporation (ACC, NZ). Average expense per claim by injury type in last 12 months. catalogue.data.govt.nz/dataset/average-expense-per-claim-by-injury-type-in-last-12-months#dataset-resources (accessed 19 June 2020).">ACC 2020</a>). The costs relate to treatment and time taken off work, with loss of income. Previously in the United Kingdom, lost productivity due to soft tissue injuries was estimated at over six million days/year (<a href="./references#CD007789-bbs2-0165" title="NichollJP , ColemanP , WilliamsBT . The epidemiology of sports and exercise related injury in the United Kingdom. British Journal of Sports Medicine1995;29(4):232-8. [PMID: 8808535]">Nicholl 1995</a>). </p> <p>Acute soft tissue injuries include a number of conditions (sprain, strain, contusion, and haematoma) with similar well‐researched and understood pathology (<a href="./references#CD007789-bbs2-0093" title="BurkeA , SmythEM , FitzgeraldGA . Analgesic-antipyretic agents. In: BruntonLL , LazoJS , ParkerKL , editors(s). Goodman and Gilman's The Pharmaceutical Basis of Therapeutics. 11 edition. NY: McGraw-Hill, 2006:671-716.">Burke 2006</a>). When the mechanical load on a tissue exceeds the tensile strength of the tissue, cell damage and haemorrhage occur. This initiates the inflammatory cascade (<a href="./references#CD007789-bbs2-0093" title="BurkeA , SmythEM , FitzgeraldGA . Analgesic-antipyretic agents. In: BruntonLL , LazoJS , ParkerKL , editors(s). Goodman and Gilman's The Pharmaceutical Basis of Therapeutics. 11 edition. NY: McGraw-Hill, 2006:671-716.">Burke 2006</a>). Inflammation clears the necrotic cell debris after traumatic haemorrhage, providing a connective tissue framework for tissue regeneration (<a href="./references#CD007789-bbs2-0151" title="MartinDJ , PalmerS . Soft tissue pain and physical therapy. Anaesthesia &amp; Intensive Care Medicine2005;6(1):23-5.">Martin 2005</a>). Pain is the most common sequela of acute soft tissue injuries, and the main reason for the use of oral analgesics. Inflammation is the natural response to such injuries, and mediators of inflammation contribute to pain and swelling following injury. Inflammation and pain are worst in the first two days post‐injury, then decline rapidly (<a href="./references#CD007789-bbs2-0076" title="AlmekindersLC , GilbertJA . Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. The American Journal of Sports Medicine1986;14(4):303-8. [PMID: 3728782]">Almekinders 1986</a>; <a href="./references#CD007789-bbs2-0093" title="BurkeA , SmythEM , FitzgeraldGA . Analgesic-antipyretic agents. In: BruntonLL , LazoJS , ParkerKL , editors(s). Goodman and Gilman's The Pharmaceutical Basis of Therapeutics. 11 edition. NY: McGraw-Hill, 2006:671-716.">Burke 2006</a>; <a href="./references#CD007789-bbs2-0166" title="ObremskyWT , SeaberAV , RibbeckBM , Garrett WE Jr. Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. American Journal of Sports Medicine1994;22(4):558-61. [PMID: 7943524]">Obremsky 1994</a>). </p> </section> <section id="CD007789-sec-0011"> <h3 class="title" id="CD007789-sec-0011">Description of the intervention</h3> <p>Analgesics are commonly prescribed, or used without prescription, for acute soft tissue injuries (<a href="./references#CD007789-bbs2-0119" title="GøtzschePC . Non-steroidal anti-inflammatory drugs. BMJ2000;320(7241):1058-61.">Gøtzsche 2000</a>; <a href="./references#CD007789-bbs2-0161" title="MotolaD , VaccheriA , SilvaniMC , PoluzziE , BottoniA , De PontiF , et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. European Journal of Clinical Pharmacology2004;60(10):731-8. [PMID: 15517225]">Motola 2004</a>; <a href="./references#CD007789-bbs2-0194" title="WarnerDC , SchnepfG , BarrettMS , DianD , SwigonskiNL . Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. Journal of Adolescent Health2002;30(3):150-3. [PMID: 11869920]">Warner 2002</a>). Traditional non‐selective non‐steroidal anti‐inflammatory drugs (NSAIDs) are the analgesic agents most often prescribed worldwide, as they have both analgesic and anti‐inflammatory effects (<a href="./references#CD007789-bbs2-0119" title="GøtzschePC . Non-steroidal anti-inflammatory drugs. BMJ2000;320(7241):1058-61.">Gøtzsche 2000</a>; <a href="./references#CD007789-bbs2-0136" title="JonesPG . Analgesia in soft-tissue injury: current practice in Auckland is not supported by the available evidence. New Zealand Medical Journal1999;112(1097):376-9. [PMID: 10587068]">Jones 1999</a>; <a href="./references#CD007789-bbs2-0161" title="MotolaD , VaccheriA , SilvaniMC , PoluzziE , BottoniA , De PontiF , et al. Pattern of NSAID use in the Italian general population: a questionnaire-based survey. European Journal of Clinical Pharmacology2004;60(10):731-8. [PMID: 15517225]">Motola 2004</a>; <a href="./references#CD007789-bbs2-0194" title="WarnerDC , SchnepfG , BarrettMS , DianD , SwigonskiNL . Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. Journal of Adolescent Health2002;30(3):150-3. [PMID: 11869920]">Warner 2002</a>). The use of NSAIDs for analgesia following an injury has been questioned, due to the high side effect profile of NSAIDs compared with that of other analgesic agents. For example, a short course (one week) of diclofenac has an associated mortality rate of 5.9 deaths per million users, compared with a rate of 0.2 per million users for paracetamol; thus, a nearly 30‐fold increased risk (<a href="./references#CD007789-bbs2-0080" title="AndradeSE , MartinezC , WalkerAM . Comparative safety evaluation of non-narcotic analgesics. Journal of Clinical Epidemiology1998;51(12):1357-65. [PMID: 10086830]">Andrade 1998</a>). The most common side effects of non‐selective NSAIDs are gastrointestinal. The incidence of these has been found to be twice as high in people receiving an NSAID for soft tissue injuries compared with a placebo (11% versus 5.5%); this equates to a number needed to treat for an additional harmful outcome (NNTH) of 19 (95% confidence interval (CI) 11 to 43; <a href="./references#CD007789-bbs2-0135" title="JonesP . NSAIDs in soft tissue injury: current practice vs. available evidence. Emergency Medicine Australasia1998;10(4):361.">Jones 1998</a>). NSAIDs can cause acute renal failure (<a href="./references#CD007789-bbs2-0175" title="Pérez GutthannS , Garcia RodriguezLA , RaifordDS , Duque OliartA , Ris RomeuJ . Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Archives of Internal Medicine1996;156(21):2433-9. [PMID: 8944736]">Pérez Gutthann 1996</a>), bronchospasm, hypersensitivity reactions (<a href="./references#CD007789-bbs2-0079" title="Amadio P Jr, CummingsDM , AmadioPB . NSAIDs revisited: selection, monitoring, and safe use. Postgraduate Medicine1997;101(2):257-60, 263-7, 270-1. [PMID: 9046939]">Amadio 1997</a>; <a href="./references#CD007789-bbs2-0091" title="BrooksPM , DayRO . Nonsteroidal antiinflammatory drugs – differences and similarities. New England Journal of Medicine1991;324(24):1716-25. [PMID: 2034249]">Brooks 1991</a>), and psychological decompensation (<a href="./references#CD007789-bbs2-0092" title="BrowningCH . Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. International Journal of Psychiatry in Medicine1996;26(1):25-34. [PMID: 8707453]">Browning 1996</a>). They have also been implicated in necrotising fasciitis, with excess risk in the first month of treatment (<a href="./references#CD007789-bbs2-0180" title="RietveldJA , PilmoreHL , JonesPG , TheisJC , BowieDA , DempsterAG , et al. Necrotising fasciitis: a single centre's experience. New Zealand Medical Journal1995;108(995):72-4. [PMID: 7891945]">Rietveld 1995</a>). Further information on adverse effects can be found in <a href="./appendices#CD007789-sec-0127">Appendix 1</a>. </p> <p>Other oral analgesic agents in common use are paracetamol (acetaminophen), and oral opioids. Opioids and paracetamol have no direct peripheral anti‐inflammatory effects. Opioids act centrally and peripherally on opioid receptors for their analgesic efficacy and other effects (<a href="./references#CD007789-bbs2-0171" title="PathanH , WilliamsJ . Basic opioid pharmacology: an update. British Journal of Pain2012;6(1):11-6.">Pathan 2012</a>). The exact mechanism of paracetamol remains unclear, but likely involves a number of inter‐related central pain pathways, including prostaglandin, serotinergic, nitric oxide, and cannabinoid pathways (<a href="./references#CD007789-bbs2-0187" title="SharmaCV , MehtaV . Paracetamol: mechanisms and updates. Continuing Education in Anaesthesia, Critical Care &amp; Pain2013;14(4):153-8. [DOI: 10.1093/bjaceaccp/mkt049]">Sharma 2013</a>). Biologically active, oral complementary and alternative medicines (CAM), such as glucosamine, have also been studied in the setting of musculoskeletal pain. Glucosamine may have inhibitory effects on cytokines involved in inflammation (<a href="./references#CD007789-bbs2-0120" title="HaghighatA , BehniaA , KavianiN , KhoramiB . Evaluation of Glucosamine sulfate and Ibuprofen effects in patients with temporomandibular joint osteoarthritis symptom. Journal of Research in Pharmacy Practice2013;2(1):34-9.">Haghighat 2013</a>). </p> <p>Recently, increasing use of a subclass of NSAIDs, the selective cyclooxygenase isoenzyme type 2 (COX‐2) inhibitors, and the centrally acting, oral opioid analgesic tramadol, has renewed interest in the topic of this review, with the publication of several trials of oral analgesics in acute soft tissue injuries in the last few years (<a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0102" title="DiazJA , CuervoC , ValderramaAM , KohlesJ . Valdecoxib provides effective pain relief following acute ankle sprain. Journal of International Medical Research2006;34(5):456-67. [PMID: 17133774]">Diaz 2006a</a>; <a href="./references#CD007789-bbs2-0105" title="EkmanEF , FiechtnerJJ , LevyS , FortJG . Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: a multicenter, double-blind, randomized controlled trial in acute ankle sprain. American Journal of Orthopedics2002;31(8):445-51. [PMID: 12216965]">Ekman 2002a</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0125" title="HewittDJ , ToddKH , XiangJ , JordanDM , RosenthalNR , CAPSS-216 Study Investigators. Tramadol/acetaminophen or hydrocodone/acetaminophen for the treatment of ankle sprain: a randomized, placebo-controlled trial. Annals of Emergency Medicine2007;49(4):468-80. [PMID: 17113683]">Hewitt 2007</a>; <a href="./references#CD007789-bbs2-0164" title="NadarajahA , AbrahanL , LauFL , HwangLJ , Fakir-BolteC . Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Singapore Medical Journal2006;47(6):534-42. [PMID: 16752024]">Nadarajah 2006a</a>; <a href="./references#CD007789-bbs2-0172" title="PetrellaR , EkmanEF , SchullerR , FortJG . Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a double-blind, randomized controlled trial. Clinical Journal of Sport Medicine2004;14(4):225-31. [PMID: 15273528]">Petrella 2004a</a>). While the selective COX‐2 inhibitors have fewer gastrointestinal side effects compared with non‐selective NSAIDs, this may be at the cost of more cardiovascular side effects, particularly with long‐term use. Little is known about the cardiovascular risk with the short‐term use of selective COX‐2 inhibitors for acute soft tissue injury (<a href="./references#CD007789-bbs2-0093" title="BurkeA , SmythEM , FitzgeraldGA . Analgesic-antipyretic agents. In: BruntonLL , LazoJS , ParkerKL , editors(s). Goodman and Gilman's The Pharmaceutical Basis of Therapeutics. 11 edition. NY: McGraw-Hill, 2006:671-716.">Burke 2006</a>; <a href="./references#CD007789-bbs2-0095" title="ChanFK . Primer: managing NSAID-induced ulcer complications – balancing gastrointestinal and cardiovascular risks. Nature Clinical Practice. Gastroenterology &amp; Hepatology2006;3(10):563-73. [PMID: 17008926]">Chan 2006</a>; <a href="./references#CD007789-bbs2-0107" title="FarkouhME , KirshnerH , HarringtonRA , RulandS , VerheugtFW , SchnitzerTJ , et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet2004;364(9435):675-84. [PMID: 15325832]">Farkouh 2004</a>; <a href="./references#CD007789-bbs2-0139" title="KearneyPM , BaigentC , GodwinJ , HallsH , EmbersonJR , PatronoC . Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ2006;332(7553):1302-8. [PMID: 16740558]">Kearney 2006</a>; <a href="./references#CD007789-bbs2-0184" title="SchnitzerTJ , BurmesterGR , MyslerE , HochbergMC , DohertyM , EhrsamE , et al. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial. Lancet2004;364(9435):665-74. [PMID: 15325831]">Schnitzer 2004</a>). </p> </section> <section id="CD007789-sec-0012"> <h3 class="title" id="CD007789-sec-0012">How the intervention might work</h3> <p>The pain and swelling that result from injury are mediated by an inflammatory process (<a href="./references#CD007789-bbs2-0093" title="BurkeA , SmythEM , FitzgeraldGA . Analgesic-antipyretic agents. In: BruntonLL , LazoJS , ParkerKL , editors(s). Goodman and Gilman's The Pharmaceutical Basis of Therapeutics. 11 edition. NY: McGraw-Hill, 2006:671-716.">Burke 2006</a>). The rationale for using NSAIDs for acute soft tissue injury is that pain and swelling are due to inflammation, so NSAIDs will improve symptoms because they reduce inflammation (<a href="./references#CD007789-bbs2-0082" title="Baldwin LanierA . Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury. Sports Medicine2003;33(3):177-85. [PMID: 12656639]">Baldwin 2003</a>; <a href="./references#CD007789-bbs2-0132" title="IvinsD . Acute ankle sprain: an update. American Family Physician2006;74(10):1714-20. [PMID: 17137000]">Ivins 2006</a>; <a href="./references#CD007789-bbs2-0155" title="MehalloCJ , DreznerJA , BytomskiJR . Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries. Clinical Journal of Sport Medicine2006;16(2):170-4. [PMID: 16603889]">Mehallo 2006</a>). However, there are counter‐arguments to the concept that NSAIDs improve healing. The first is that in this setting, inflammation is integral to the healing process, and by reducing inflammation, healing may be impaired (<a href="./references#CD007789-bbs2-0149" title="MajorP . Should non-steroidal anti-inflammatory agents be used in acute soft tissue injuries? [Bor ikke-steroide antiinflammatoriske midler brukes ved akutte blotdelsskader?]. Tidsskrift for den Norske Laegeforening1992;112(12):1614-5. [PMID: 1535465]">Major 1992</a>; <a href="./references#CD007789-bbs2-0168" title="PaoloniJA , OrchardJW . The use of therapeutic medications for soft-tissue injuries in sports medicine. Medical Journal of Australia2005;183(7):384-8. [PMID: 16201960]">Paoloni 2005</a>). The second is that NSAIDs delay, but do not reduce, the inflammatory response to injury (<a href="./references#CD007789-bbs2-0076" title="AlmekindersLC , GilbertJA . Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. The American Journal of Sports Medicine1986;14(4):303-8. [PMID: 3728782]">Almekinders 1986</a>; <a href="./references#CD007789-bbs2-0136" title="JonesPG . Analgesia in soft-tissue injury: current practice in Auckland is not supported by the available evidence. New Zealand Medical Journal1999;112(1097):376-9. [PMID: 10587068]">Jones 1999</a>). This means the putative benefit of using an NSAID for acute soft tissue injuries may not be realised. </p> <p>We describe the common side effects of NSAIDs in the previous section. Opioids are known to cause sedation, respiratory depression, nausea, vomiting, constipation, diuresis, and dysphoria, depending on which opioid receptors are most stimulated (<a href="./references#CD007789-bbs2-0171" title="PathanH , WilliamsJ . Basic opioid pharmacology: an update. British Journal of Pain2012;6(1):11-6.">Pathan 2012</a>). Paracetamol in prescribed doses has not been shown to have more adverse events than placebo, when used for up to three months for osteoarthritis, other than elevation of liver function tests in approximately five per cent of people (<a href="./references#CD007789-bbs2-0147" title="LeopoldinoAO , MachadoGC , FerreiraPH , PinheiroMB , DayR , McLachlanAJ , et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database of Systematic Reviews2019, Issue 2. Art. No: CD013273. [DOI: 10.1002/14651858.CD013273]">Leopoldino 2019</a>). This is consistent with the known hepatoxicity of paracetamol when taken in overdose (<a href="./references#CD007789-bbs2-0169" title="ParkBK , DearJW , AntoineDJ . Paracetamol (acetaminophen) poisoning. BMJ Clinical Evidence2015;2015:2101.">Park 2015</a>). </p> </section> <section id="CD007789-sec-0013"> <h3 class="title" id="CD007789-sec-0013">Why it is important to do this review</h3> <p>This is an update of a Cochrane Review first published in 2015 (<a href="./references#CD007789-bbs2-0202" title="JonesP , DalzielSR , LamdinR , Miles-ChanJL , FramptonC . Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database of Systematic Reviews2015, Issue 7. Art. No: CD007789. [DOI: 10.1002/14651858.CD007789.pub2]">Jones 2015</a>). Prior to 2015, narrative reviews reached different conclusions; some recommended NSAIDs for acute soft tissue injuries (<a href="./references#CD007789-bbs2-0082" title="Baldwin LanierA . Use of nonsteroidal anti-inflammatory drugs following exercise-induced muscle injury. Sports Medicine2003;33(3):177-85. [PMID: 12656639]">Baldwin 2003</a>; <a href="./references#CD007789-bbs2-0132" title="IvinsD . Acute ankle sprain: an update. American Family Physician2006;74(10):1714-20. [PMID: 17137000]">Ivins 2006</a>; <a href="./references#CD007789-bbs2-0155" title="MehalloCJ , DreznerJA , BytomskiJR . Practical management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries. Clinical Journal of Sport Medicine2006;16(2):170-4. [PMID: 16603889]">Mehallo 2006</a>); while others argued that they may be harmful (<a href="./references#CD007789-bbs2-0136" title="JonesPG . Analgesia in soft-tissue injury: current practice in Auckland is not supported by the available evidence. New Zealand Medical Journal1999;112(1097):376-9. [PMID: 10587068]">Jones 1999</a>; <a href="./references#CD007789-bbs2-0149" title="MajorP . Should non-steroidal anti-inflammatory agents be used in acute soft tissue injuries? [Bor ikke-steroide antiinflammatoriske midler brukes ved akutte blotdelsskader?]. Tidsskrift for den Norske Laegeforening1992;112(12):1614-5. [PMID: 1535465]">Major 1992</a>; <a href="./references#CD007789-bbs2-0168" title="PaoloniJA , OrchardJW . The use of therapeutic medications for soft-tissue injuries in sports medicine. Medical Journal of Australia2005;183(7):384-8. [PMID: 16201960]">Paoloni 2005</a>). Some reviews found the evidence inconclusive (<a href="./references#CD007789-bbs2-0119" title="GøtzschePC . Non-steroidal anti-inflammatory drugs. BMJ2000;320(7241):1058-61.">Gøtzsche 2000</a>; <a href="./references#CD007789-bbs2-0124" title="HertelJ . The role of nonsteroidal anti-inflammatory drugs in the treatment of acute soft tissue injuries. Journal of Athletic Training1997;32(4):350-8. [PMID: 16558472]">Hertel 1997</a>). Contributing to this uncertainty were conflicting reports of the effect of NSAIDs on inflammation in both animal and human models (<a href="./references#CD007789-bbs2-0076" title="AlmekindersLC , GilbertJA . Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. The American Journal of Sports Medicine1986;14(4):303-8. [PMID: 3728782]">Almekinders 1986</a>; <a href="./references#CD007789-bbs2-0077" title="AlmekindersLC , BaynesAJ , BraceyLW . An in vitro investigation into the effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts. American Journal of Sports Medicine1995;23(1):119-23. [PMID: 7726341]">Almekinders 1995</a>; <a href="./references#CD007789-bbs2-0089" title="BogatovVB , WeinholdP , DahnersLE . The influence of a cyclooxygenase-1 inhibitor on injured and uninjured ligaments in the rat. American Journal of Sports Medicine2003;31(4):574-6. [PMID: 12860547]">Bogatov 2003</a>; <a href="./references#CD007789-bbs2-0166" title="ObremskyWT , SeaberAV , RibbeckBM , Garrett WE Jr. Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. American Journal of Sports Medicine1994;22(4):558-61. [PMID: 7943524]">Obremsky 1994</a>; <a href="./references#CD007789-bbs2-0177" title="RahusenFT , WeinholdPS , AlmekindersLC . Nonsteroidal anti-inflammatory drugs and acetaminophen in the treatment of an acute muscle injury. American Journal of Sports Medicine2004;32(8):1856-9. [PMID: 15572312]">Rahusen 2004</a>), and a paucity of evidence that NSAIDs are superior to other analgesics in clinical studies (<a href="./references#CD007789-bbs2-0098" title="De GaraC , TaylorM , HedgesA . Assessment of analgesic drugs in soft tissue injuries presenting to an accident and emergency department--a comparison of antrafenine, paracetamol and placebo. Postgraduate Medical Journal1982;58(682):489-92. [PMID: 6752926]">De Gara 1982a</a>; <a href="./references#CD007789-bbs2-0200" title="YatesDW , LaingGS , PetersK , KumarK . Mild analgesics and the accident and emergency department – cost and safety more important than potency?Archives of Emergency Medicine1984;1(4):197-203.">Yates 1984a</a>). These initial reviews were criticised on the basis of the poor quality of included studies, non‐systematic methods (<a href="./references#CD007789-bbs2-0097" title="Centre for Reviews and Dissemination (CRD). Treatment modalities for soft tissue injuries of the ankle: a critical review. www.mrw.interscience.wiley.com/cochrane/cldare/articles/DARE-951779/frame.html1997.">CRD 2007</a>), and variable outcome reporting that hindered meta‐analysis (<a href="./references#CD007789-bbs2-0167" title="Ogilvie-HarrisDJ , GilbartM . Treatment modalities for soft tissue injuries of the ankle: a critical review. Clinical Journal of Sport Medicine1995;5(3):175-86. [PMID: 7670974]">Ogilvie‐Harris 1995</a>). Athough we successfully addressed some of these concerns, the previous version of this review still found a paucity of available evidence, and imprecise results for some outcomes. There is recent concern that oral opioid prescription in the acute setting is increasing, and is associated with the development of opioid dependence (<a href="./references#CD007789-bbs2-0086" title="BarnettML , OlenskiAR , JenaAB . Opioid-prescribing patterns of emergency physicians and risk of long-term use. New England Journal of Medicine2017;376(7):663-73.">Barnett 2017</a>). With the publication of new studies of oral analgesic agents for acute soft tissue injuries, it was timely to update this systematic review of NSAIDs compared with other analgesics for these injuries. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007789-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007789-sec-0014"></div> <p>To assess the effects (benefits and harms) of oral non‐steroidal anti‐inflammatory drugs (NSAIDs) compared with other oral analgesics for treating acute soft tissue injuries. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007789-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007789-sec-0015"></div> <section id="CD007789-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007789-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered all randomised controlled trials (RCTs) and quasi‐randomised (method of allocating participants to a treatment that is not strictly random, e.g. by date of birth, hospital record number, alternation) controlled trials comparing an oral non‐steroidal anti‐inflammatory drug (NSAID) with a different class of oral analgesic agent for the treatment of acute soft tissue injuries. We excluded cross‐over trials, which are inappropriate for short‐term conditions, and cluster‐randomised trials. </p> </section> <section id="CD007789-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included participants with an acute soft tissue injury. We defined this as follows:</p> <p> <ul id="CD007789-list-0001"> <li> <p>soft tissue injury = sprain, strain, or contusion (haematoma) of a joint, ligament, tendon, or muscle; and </p> </li> <li> <p>acute = injury occurring &lt; 48 hours prior to inclusion in the study. We included studies with a clear majority of participants meeting this criterion (≥ 70%). </p> </li> </ul> </p> <p>We had no restrictions based on age, sex, ethnicity, or study site.</p> <p>We excluded studies if they focused on back pain, cervical spine injury, repetitive strain injuries, delayed onset muscle soreness, or primary inflammatory conditions (such as tendonitis or arthritis), as these conditions have either a different natural history, or reflect a different disease process. </p> </section> <section id="CD007789-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We considered oral analgesic agents commonly prescribed for treating acute soft tissue injuries, grouped by their local anti‐inflammatory effects. </p> <p>We considered studies in which the intervention was to be completed within one month (30 days) of the injury, as by this time, most of the uncomplicated acute soft tissue injuries should have healed (<a href="./references#CD007789-bbs2-0076" title="AlmekindersLC , GilbertJA . Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. The American Journal of Sports Medicine1986;14(4):303-8. [PMID: 3728782]">Almekinders 1986</a>; <a href="./references#CD007789-bbs2-0152" title="McClellanCM , GreenwoodR , BengerJR . Effect of an extended scope physiotherapy service on patient satisfaction and the outcome of soft tissue injuries in an adult emergency department. Emergency Medicine Journal2006;23(5):384-7. [PMID: 16627842]">McClellan 2006</a>). We included studies of oral NSAIDs versus oral comparators. </p> <p>The groups for comparison were:</p> <p> <ul id="CD007789-list-0002"> <li> <p>NSAID versus paracetamol (acetaminophen);</p> </li> <li> <p>NSAID versus opioid;</p> </li> <li> <p>NSAID versus combination analgesics (see below); and</p> </li> <li> <p>NSAID versus complementary and alternative medicine; we planned to group these according to biological activity (<a href="./references#CD007789-bbs2-0144" title="KoithanM . Introducing complementary and alternative therapies. Journal for Nurse Practitioners2009;5(1):18-20.">Koithan 2009</a>). </p> </li> </ul> </p> <p>There are many combination analgesics containing different analgesics, with or without other agents (<a href="./references#CD007789-bbs2-0081" title="Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Acute pain management: scientific evidence. www.anzca.edu.au/resources/books-and-publications/acutepain.pdf (accessed April 2008).">ANZCA 2005</a>; <a href="./references#CD007789-bbs2-0083" title="Bandolier Extra. Combination analgesics. www.medicine.ox.ac.uk/bandolier/Extraforbando/combo.pdf (accessed 31 July 2008).">Bandolier 2005</a>). We grouped these analgesics according to anti‐inflammatory and opiate constituents if they were sufficiently similar (NSAID and opioid; NSAID and paracetamol; paracetamol and opioid; <a href="./references#CD007789-bbs2-0153" title="McNicolED , StrasselsS , GoudasL , LauJ , CarrDB . NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database of Systematic Reviews2005, Issue 2. Art. No: CD005180. [DOI: 10.1002/14651858.CD005180]">McNicol 2005</a>). We only included comparisons of NSAID versus the paracetamol and opioid combination. </p> <p>We excluded studies comparing COX‐2 selective NSAIDs versus non‐selective NSAIDs.</p> </section> <section id="CD007789-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>When treating acute soft tissue injuries, pain, swelling, functional improvement, and adverse effects are of particular interest (<a href="./references#CD007789-bbs2-0140" title="KellettJ . Acute soft tissue injuries – a review of the literature. Medicine and Science in Sports and Exercise1986;18(5):489-500. [PMID: 3534506]">Kellett 1986</a>; <a href="./references#CD007789-bbs2-0168" title="PaoloniJA , OrchardJW . The use of therapeutic medications for soft-tissue injuries in sports medicine. Medical Journal of Australia2005;183(7):384-8. [PMID: 16201960]">Paoloni 2005</a>; <a href="./references#CD007789-bbs2-0195" title="WeilerJM . Medical modifiers of sports injury. The use of nonsteroidal anti-inflammatory drugs (NSAIDs) in sports soft-tissue injury. Clinics in Sports Medicine1992;11(3):625-44. [PMID: 1638643]">Weiler 1992</a>). See <a href="#CD007789-sec-0035">Measures of treatment effect</a> for further consideration on outcomes, including timing. More details of the measures listed below are provided in <a href="#CD007789-sec-0035">Measures of treatment effect</a>. </p> <p>We did not seek economic data for this review.</p> <section id="CD007789-sec-0021"> <h5 class="title">Primary outcomes</h5> <section id="CD007789-sec-0022"> <h6 class="title">Pain</h6> <p>Our primary outcome measure was pain. Owing to its subjective nature, there is no standard method for reporting pain (<a href="./references#CD007789-bbs2-0131" title="International Association for the Study of Pain (IASP). IASP pain terminology. www.iasp-pain.org/AM/Template.cfm?Section=General_Resource_Links&amp;Template=/CM/HTMLDisplay.cfm&amp;ContentID=3058#Painz (accessed 31 July 2008).">IASP 2007</a>). Consequently, different authors recorded pain in different ways, generally using categorical or visual analogue scales, and at different time points (<a href="./references#CD007789-bbs2-0130" title="HonigS . Clinical trials in acute musculoskeletal injury states. An analysis of methodology. American Journal of Medicine1988;84(5A):42-4. [PMID: 3376973]">Honig 1988</a>). </p> </section> </section> <section id="CD007789-sec-0023"> <h5 class="title">Secondary outcomes</h5> <section id="CD007789-sec-0024"> <h6 class="title">Swelling</h6> <p>We sought data for both subjectively reported and objectively measured swelling, which is considered a surrogate marker of inflammation. We collected both categorical and continuous data. </p> </section> <section id="CD007789-sec-0025"> <h6 class="title">Function</h6> <p>We sought data for self‐reported assessment of function, functional impairment, and the proportion of people who had returned to function at prespecified time points. </p> </section> <section id="CD007789-sec-0026"> <h6 class="title">Adverse effects</h6> <p>Potential adverse events of NSAIDs and other oral analgesics include gastrointestinal tract upset, renal disease, cardiovascular events, central nervous system side effects, respiratory depression, haematological abnormalities, skin photosensitivity, allergic reactions (rashes, throat swelling, wheeze, stridor), and necrotising fasciitis or soft tissue infections. We classified these events as serious if they led to death or admission to hospital (or the review authors thought it likely to lead to admission, if not stated in the report); required invasive intervention or monitoring (endoscopy, intermittent positive pressure ventilation, intramuscular or intravenous adrenalin); or needed resuscitation with crystalloid, colloid, or blood transfusion. We classed other adverse effects as minor. </p> <p>Gastrointestinal adverse events were nausea, vomiting, dyspepsia, abdominal pain, peptic ulcer disease, gastrointestinal bleeding, hepatic dysfunction, diarrhoea, constipation, and other, if reported. </p> <p>Neurological adverse effects were drowsiness or somnolence, dizziness or vertigo, headache, paraesthesia, seizure, and other, if reported. </p> </section> <section id="CD007789-sec-0027"> <h6 class="title">Early re‐injury</h6> <p>We sought data on the recurrence of injury within three months, and time to re‐injury.</p> </section> </section> </section> </section> <section id="CD007789-sec-0028"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007789-sec-0029"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2020 Issue 1) in the Cochrane Library (searched 29 January 2020); MEDLINE Ovid (Medline, Epub Ahead of Print, In‐process &amp; Other non‐indexed citations, Daily and Versions; 1946 to 28 January 2020); Embase (1980 to 29 January 2020); Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1937 to 12 February 2019); Allied and Complementary Medicine (AMED; 1985 to 12 February 2019); International Pharmaceutical Abstracts (1970 to 12 February 2019); the <a href="http://www.pedro.org.au/" target="_blank">Physiotherapy Evidence Database</a> (PEDro; 1929 to 11 March 2019); and SPORTDiscus (1985 to 12 February 2019). The initial search was run in February 2019 for all databases, and a top‐up search was run in January 2020 in the three main databases: CENTRAL, MEDLINE, and Embase. We did not place any restrictions based on language. </p> <p>At the time of the search, CENTRAL was fully up‐to‐date with all records from the Bone Joint Muscle Trauma (BJMT) Group’s Specialised Register, and so it was not necessary to search this separately. For this update, we limited the searches were limited from the date of the previous searches to present: 2014 for CENTRAL, MEDLINE, and Embase, and 2012 for CINAHL, AMED, International Pharmaceutical Abstracts, and SPORTDiscus. Details of the search strategies used for the previous review are given in <a href="./references#CD007789-bbs2-0202" title="JonesP , DalzielSR , LamdinR , Miles-ChanJL , FramptonC . Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database of Systematic Reviews2015, Issue 7. Art. No: CD007789. [DOI: 10.1002/14651858.CD007789.pub2]">Jones 2015</a>. </p> <p>We also searched trial registries, <a href="https://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> (19 February 2019), and the <a href="http://www.who.int/ictrp/en/" target="_blank">World Health Organization International Clinical Trials Registry platform</a> (WHO ICTRP; 18 February 2019), for ongoing and recently completed trials. </p> <p>In MEDLINE, we combined the subject‐specific strategy with the sensitivity‐maximising version of the Cochrane highly sensitive search strategy for identifying randomised trials (<a href="./references#CD007789-bbs2-0146" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Lefebvre 2011</a>). See <a href="./appendices#CD007789-sec-0137">Appendix 2</a> for details of all search strategies. </p> </section> <section id="CD007789-sec-0030"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of retrieved articles. We contacted authors of retrieved studies to obtain relevant unpublished data, such as summary statistics if the published report did not contain these, or to ascertain whether a potentially relevant trial met the review inclusion criteria when this was unclear. We also contacted experts in the field and pharmaceutical companies to identify unpublished trials. </p> </section> </section> <section id="CD007789-sec-0031"> <h3 class="title" id="CD007789-sec-0031">Data collection and analysis</h3> <section id="CD007789-sec-0032"> <h4 class="title">Selection of studies</h4> <p>Two review authors, who were not blinded to trial authors or results, independently assessed studies for eligibility. They resolved any disagreement by discussion. Where necessary, we attempted to contact authors for further information. We saved details of searches (database, host, years covered, date and results) and present them in <a href="./appendices#CD007789-sec-0137">Appendix 2</a>. </p> </section> <section id="CD007789-sec-0033"> <h4 class="title">Data extraction and management</h4> <p>Using a piloted form, two review authors independently extracted data for the listed outcomes. They resolved discrepancies by consensus, or adjudication by a third review author. Where necessary, we contacted trialists for additional and missing data. </p> </section> <section id="CD007789-sec-0034"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias in the included studies using the 'Risk of bias' tool described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007789-bbs2-0127" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We graded each study's potential bias in each of the following domains: sequence generation, allocation concealment, blinding (treatment providers, participants, outcome assessors), incomplete outcome data (pain, swelling, function, adverse effects), selective outcome reporting, and 'other'. For each study, we described the domains as reported (or after discussion with the trial authors), and judged their risk of bias. Our judgements were 'low', 'unclear' or 'high' risk of bias. We judged bias as 'unclear' if there was insufficient detail to make a judgement. The two review authors resolved disagreements regarding the risk of bias for domains by consensus. </p> </section> <section id="CD007789-sec-0035"> <h4 class="title">Measures of treatment effect</h4> <p>Pain, swelling, and return to function are time dependent, as are the effects of the interventions (medicines with different times of onset and duration of effect). Therefore, we analysed these outcomes at different time intervals from the onset of treatment, based on the pathophysiology of acute soft tissue injury, and pharmacology of interventions discussed above, to minimise the 'effect modification' of time on pain and swelling (<a href="./references#CD007789-bbs2-0115" title="GlasziouPP , SandersSL . Investigating causes of heterogeneity in systematic reviews. Statistics in Medicine2002;21(11):1503-11. [PMID: 12111916]">Glasziou 2002</a>). If a trial did not report a relevant outcome at one of the specified time intervals, we did not include data from that study in the meta‐analysis. We used 95% confidence intervals (CI) throughout. </p> <section id="CD007789-sec-0036"> <h5 class="title">Primary outcome</h5> <section id="CD007789-sec-0037"> <h6 class="title">Pain</h6> <p>Some trials reported pain on a continuous scale, others used a categorical scale, and some used both. We analysed the meta‐analysis of continuous and categorical pain outcomes separately. </p> <section id="CD007789-sec-0038"> <p><b>Continuous data</b></p> <p>For acute pain, a standard linear 10‐cm visual analogue scale (VAS‐10) has been shown to be a valid measurement tool, regardless of the severity of pain (<a href="./references#CD007789-bbs2-0162" title="MylesPS , TroedelS , BoquestM , ReevesM . The pain visual analog scale: Is it linear or nonlinear?Anesthesia and Analgesia1999;89(6):1517-20. [PMID: 10589640]">Myles 1999</a>; <a href="./references#CD007789-bbs2-0163" title="MylesPS , UrquhartN . The linearity of the visual analogue scale in patients with severe acute pain. Anaesthesia and Intensive Care2005;33(1):54-8. [PMID: 15957691]">Myles 2005</a>). In comparison, chronic pain has been shown to be non‐linear, possibly due to changes in the pain experience over time (<a href="./references#CD007789-bbs2-0148" title="LundI , LundebergT , SandbergL , BudhCN , KowalskiJ , SvenssonE . Lack of interchangeability between visual analogue and verbal rating pain scales: a cross sectional description of pain etiology groups. BMC Medical Research Methodology2005;5:31. [PMID: 16202149]">Lund 2005</a>; <a href="./references#CD007789-bbs2-0176" title="QuidingH , HäggquistSO . Visual analogue scale and the analysis of analgesic action. European Journal of Clinical Pharmacology1983;24(4):475-8. [PMID: 6861862]">Quiding 1983</a>; <a href="./references#CD007789-bbs2-0189" title="SvenssonE . Concordance between ratings using different scales for the same variable. Statistics in Medicine2000;19(24):3483-96. [PMID: 11122509]">Svensson 2000</a>; <a href="./references#CD007789-bbs2-0198" title="deC WilliamsAC , DaviesHT , ChaduryY . Simple pain rating scales hide complex idiosyncratic meanings. Pain2000;85(3):457-63. [PMID: 10781919]">Williams 2000</a>). The minimum clinically important difference (MCID) in acute pain scores using a 100‐mm VAS scale is 13 mm, regardless of age and baseline pain severity, equivalent to a one‐point change on a five‐point categorical scale (<a href="./references#CD007789-bbs2-0085" title="BardenJ , EdwardsJE , MasonL , McQuayHJ , MooreRA . Outcomes in acute pain trials: systematic review of what was reported?Pain2004;109(3):351-6. [PMID: 15157696]">Barden 2004</a>; <a href="./references#CD007789-bbs2-0088" title="BijurPE , LatimerCT , GallagherEJ . Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Academic Emergency Medicine2003;10(4):390-2. [PMID: 12670856]">Bijur 2003</a>; <a href="./references#CD007789-bbs2-0106" title="FalgaroneG , ZerkakD , BauerC , MessowM , DougadosM . How to define a Minimal Clinically Individual State (MCIS) with pain VAS in daily practice for patients suffering from musculoskeletal disorders. Clinical and Experimental Rheumatology2005;23(2):235-8. [PMID: 15895896]">Falgarone 2005</a>; <a href="./references#CD007789-bbs2-0110" title="FosnochtDE , ChapmanCR , SwansonER , DonaldsonGW . Correlation of change in visual analog scale with pain relief in the ED. American Journal of Emergency Medicine2005;23(1):55-9. [PMID: 15672339]">Fosnocht 2005</a>; <a href="./references#CD007789-bbs2-0111" title="GallagherEJ , LiebmanM , BijurPE . Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Annals of Emergency Medicine2001;38(6):633-8. [PMID: 11719741]">Gallagher 2001</a>; <a href="./references#CD007789-bbs2-0112" title="GallagherEJ , BijurPE , LatimerC , SilverW . Reliability and validity of a visual analog scale for acute abdominal pain in the ED. American Journal of Emergency Medicine2002;20(4):287-90. [PMID: 12098173]">Gallagher 2002</a>; <a href="./references#CD007789-bbs2-0141" title="KellyAM . Does the clinically significant difference in visual analog scale pain scores vary with gender, age, or cause of pain?Academic Emergency Medicine1998;5(11):1086-90. [PMID: 9835471]">Kelly 1998</a>; <a href="./references#CD007789-bbs2-0142" title="KellyAM . The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emergency Medicine Journal2001;18(3):205-7. [PMID: 11354213]">Kelly 2001</a>; <a href="./references#CD007789-bbs2-0145" title="LeeJS , HobdenE , StiellIG , WellsGA . Clinically important change in the visual analog scale after adequate pain control. Academic Emergency Medicine2003;10(10):1128-30. [PMID: 14525749]">Lee 2003</a>; <a href="./references#CD007789-bbs2-0174" title="PowellCV , KellyAM , WilliamsA . Determining the minimum clinically significant difference in visual analog pain score for children. Annals of Emergency Medicine2001;37(1):28-31. [PMID: 11145767]">Powell 2001</a>; <a href="./references#CD007789-bbs2-0182" title="SaloD , EgetD , LaveryRF , GarnerL , BernsteinS , TandonK . Can patients accurately read a visual analog pain scale?American Journal of Emergency Medicine2003;21(7):515-9. [PMID: 14655227]">Salo 2003</a>). However, a more clinically meaningful change for people is 30 mm (<a href="./references#CD007789-bbs2-0087" title="BerghI , SjostromB , OdenA , SteenB . Assessing pain and pain relief in geriatric patients with non-pathological fractures with different rating scales. Aging Clinical and Experimental Research2001;13(5):355-61. [PMID: 11820708]">Bergh 2001</a>; <a href="./references#CD007789-bbs2-0108" title="FarrarJT , BerlinJA , StromBL . Clinically important changes in acute pain outcome measures: a validation study. Journal of Pain and Symptom Management2003;25(5):406-11. [PMID: 12727037]">Farrar 2003</a>; <a href="./references#CD007789-bbs2-0133" title="JensenMP , MartinSA , CheungR . The meaning of pain relief in a clinical trial. Journal of Pain2005;6(6):400-6. [PMID: 15943962]">Jensen 2005</a>; <a href="./references#CD007789-bbs2-0145" title="LeeJS , HobdenE , StiellIG , WellsGA . Clinically important change in the visual analog scale after adequate pain control. Academic Emergency Medicine2003;10(10):1128-30. [PMID: 14525749]">Lee 2003</a>). </p> <p>VAS‐10 scores are skewed. The skew shifts with time as pain subsides (<a href="./references#CD007789-bbs2-0114" title="GeraciM , BottaiM . Quantile regression for longitudinal data using the asymmetric Laplace distribution. Biostatistics2007;8(1):140-54. [PMID: 16636139]">Geraci 2007</a>; <a href="./references#CD007789-bbs2-0181" title="RosenDA , MorrisJL , RosenKR , ValenzuelaRC , VidulichMG , SteelmanRJ , et al. Analgesia for pediatric thoracostomy tube removal. Anesthesia and Analgesia2000;90(5):1025-8. [PMID: 10781447]">Rosen 2000</a>). This may invalidate summarising mean data from VAS‐10 scores using parametric methods, and there are currently no tools available to pool data using medians (<a href="./references#CD007789-bbs2-0078" title="AltmanDG . Statistics in medical journals: some recent trends. Statistics in Medicine2000;19(23):3275-89. [PMID: 1113959]">Altman 2000</a>; <a href="./references#CD007789-bbs2-0114" title="GeraciM , BottaiM . Quantile regression for longitudinal data using the asymmetric Laplace distribution. Biostatistics2007;8(1):140-54. [PMID: 16636139]">Geraci 2007</a>; <a href="./references#CD007789-bbs2-0176" title="QuidingH , HäggquistSO . Visual analogue scale and the analysis of analgesic action. European Journal of Clinical Pharmacology1983;24(4):475-8. [PMID: 6861862]">Quiding 1983</a>). However, according to the Central Limit Theorem, the distribution of means of samples of a skewed distribution, will approximate normal for sample sizes over 15 (<a href="./references#CD007789-bbs2-0143" title="KirkwoodBR , SterneJAC . Medical Statistics. 2nd edition. Oxford: Blackwell, 2003.">Kirkwood 2003</a>). This has proven to be robust in computer simulations (<a href="./references#CD007789-bbs2-0101" title="DexterF , ChestnutDH . Analysis of statistical tests to compare visual analog scale measurements among groups. Anesthesiology1995;82(4):896-902. [PMID: 7717561]">Dexter 1995</a>; <a href="./references#CD007789-bbs2-0173" title="PhilipBK . Parametric statistics for evaluation of the visual analog scale. Anesthesia and Analgesia1990;71(6):710. [PMID: 2240648]">Philip 1990</a>). </p> <p>We used mean differences (95% CI) to summarise VAS‐10 scores across studies. We carried out all analyses on an intention‐to‐treat basis. </p> <p>We derived dichotomous outcomes from VAS plots over time, a method developed to get around the issue of skew in single dose, postoperative pain studies (<a href="./references#CD007789-bbs2-0157" title="MooreA , McQuayH , GavaghanD . Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics. Pain1996;66(2-3):229-37. [PMID: 8880845]">Moore 1996</a>; <a href="./references#CD007789-bbs2-0158" title="MooreA , MooreO , McQuayH , GavaghanD . Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales. Pain1997;69(3):311-5. [PMID: 9085306]">Moore 1997</a>). However, we considered this inappropriate for longer trials (<a href="./references#CD007789-bbs2-0160" title="MooreA . Advice on derivation of dichotomous data from graphs of VAS scores [personal communication]. Email to: P Jones 10 September 2007.">Moore 2007</a>), and now also consider it a poor reflection of the truth, even for single dose short‐term trials (<a href="./references#CD007789-bbs2-0085" title="BardenJ , EdwardsJE , MasonL , McQuayHJ , MooreRA . Outcomes in acute pain trials: systematic review of what was reported?Pain2004;109(3):351-6. [PMID: 15157696]">Barden 2004</a>). </p> </section> <section id="CD007789-sec-0039"> <p><b>Categorical data</b></p> <p>For studies reporting analgesic effect using a categorical scale, we collapsed data into the proportion of participants experiencing 'good' or 'complete' pain relief, where possible. This method has previously been recommended to compare analgesics using five‐point scales (<a href="./references#CD007789-bbs2-0159" title="MooreRA , EdwardsJE , McQuayHJ . Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results. Pain2005;116(3):322-31. [PMID: 15979792]">Moore 2005</a>), as it facilitates analysis and interpretation, albeit at the cost of some lost information (<a href="./references#CD007789-bbs2-0078" title="AltmanDG . Statistics in medical journals: some recent trends. Statistics in Medicine2000;19(23):3275-89. [PMID: 1113959]">Altman 2000</a>; <a href="./references#CD007789-bbs2-0096" title="Cochrane Collaboration open learning material for reviewers Version 11. Summary statistics for dichotomous outcome data. www.cochrane-net.org/openlearning/HTML/modA1-5.htm (accessed April 2008).">Cochrane 2002</a>). </p> <p>Similarly, if studies used different categorical scales, we collapsed them according to the following schedule. </p> <p> <ul id="CD007789-list-0003"> <li> <p>3‐point: lowest two categories 'no pain relief', and one highest 'good pain relief'</p> </li> <li> <p>4‐point: lowest three categories 'no pain relief', and one highest 'good pain relief'</p> </li> <li> <p>5‐point: lowest three categories 'no pain relief', and two highest 'good pain relief'</p> </li> <li> <p>6‐point: lowest four categories 'no pain relief', and two highest 'good pain relief'</p> </li> <li> <p>7‐point: lowest four categories 'no pain relief', and three highest 'good pain relief'</p> </li> <li> <p>8‐point: lowest five categories 'no pain relief', and three highest 'good pain relief'.</p> </li> <li> <p>9‐point: lowest five categories 'no pain relief', and four highest 'good pain relief'.</p> </li> <li> <p>10‐point: lowest six categories 'no pain relief', and four highest 'good pain relief'.</p> </li> </ul> </p> <p>For all dichotomised data, we reported risk ratios (RR, 95% CI). We analysed outcomes on an intention‐to‐treat basis. For acute soft tissue injuries pain, RR is appropriate to report as event rates are high (typically &gt; 50%) in this setting, and using odds ratios (OR) may lead to overestimation of the differences between interventions (<a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0102" title="DiazJA , CuervoC , ValderramaAM , KohlesJ . Valdecoxib provides effective pain relief following acute ankle sprain. Journal of International Medical Research2006;34(5):456-67. [PMID: 17133774]">Diaz 2006a</a>). </p> <p>We recognise that there are limitations of using RRs, which vary, depending on which intervention is chosen as the 'control', and are bounded by the event rate (<a href="./references#CD007789-bbs2-0099" title="DeeksJ , AltmanDG . Chapter 16: Effect measures for meta-analysis of trials with binary outcomes. In: EggerM , SmithGD , AltmanDG , editors(s). Systematic Reviews. 2nd edition. London: BMJ, 2001:313-5.">Deeks 2001</a>). Reflecting this lack of a standard approach (<a href="./references#CD007789-bbs2-0100" title="DeeksJJ . Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine2002;21(11):1575-600. [PMID: 12111921]">Deeks 2002</a>), previous review authors have reported either OR or RR (<a href="./references#CD007789-bbs2-0084" title="Bandolier. Oxford league table of analgesics in acute pain. www.jr2.ox.ac.uk/bandolier/booth/painpag/Acutrev/Analgesics/Leagtab.html (accessed 31 July 2008).">Bandolier 2007</a>; <a href="./references#CD007789-bbs2-0150" title="ManterolaC , VialM , MoragaJ , AstudilloP . Analgesia in patients with acute abdominal pain. Cochrane Database of Systematic Reviews2007, Issue 3. Art. No: CD005660. [DOI: 10.1002/14651858.CD005660.pub2]">Manterola 2007</a>; <a href="./references#CD007789-bbs2-0196" title="WiffenPJ , DerryS , MooreRA , McQuayHJ . Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews2005, Issue 3. Art. No: CD005451. [DOI: 10.1002/14651858.CD005451]">Wiffen 2005</a>). Another alternative, risk difference (RD), depends on baseline risk, and is unlikely to be consistent between trials (<a href="./references#CD007789-bbs2-0099" title="DeeksJ , AltmanDG . Chapter 16: Effect measures for meta-analysis of trials with binary outcomes. In: EggerM , SmithGD , AltmanDG , editors(s). Systematic Reviews. 2nd edition. London: BMJ, 2001:313-5.">Deeks 2001</a>). We performed a sensitivity analysis for our results with RR by repeating the analysis with both OR and RD, checking for consistency, variance, and ease of interpretation (<a href="./references#CD007789-bbs2-0099" title="DeeksJ , AltmanDG . Chapter 16: Effect measures for meta-analysis of trials with binary outcomes. In: EggerM , SmithGD , AltmanDG , editors(s). Systematic Reviews. 2nd edition. London: BMJ, 2001:313-5.">Deeks 2001</a>; <a href="./references#CD007789-bbs2-0100" title="DeeksJJ . Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine2002;21(11):1575-600. [PMID: 12111921]">Deeks 2002</a>). </p> <p>Where trials reported categorical data as a mean with a standard deviation (SD), we only included studies with scales of 10 points or more (<a href="./references#CD007789-bbs2-0088" title="BijurPE , LatimerCT , GallagherEJ . Validation of a verbally administered numerical rating scale of acute pain for use in the emergency department. Academic Emergency Medicine2003;10(4):390-2. [PMID: 12670856]">Bijur 2003</a>; <a href="./references#CD007789-bbs2-0123" title="HerbisonP . Statistical advice [Personal communication] 15 September 2008.">Herbison 2008</a>). </p> <p>We analysed pain at the following time points.</p> <p> <ul id="CD007789-list-0004"> <li> <p>First 24 hours</p> </li> <li> <p>Days one to three (the time of maximum pain related to acute injury (<a href="./references#CD007789-bbs2-0135" title="JonesP . NSAIDs in soft tissue injury: current practice vs. available evidence. Emergency Medicine Australasia1998;10(4):361.">Jones 1998</a>)) </p> </li> <li> <p>Days four to six (if reported (<a href="./references#CD007789-bbs2-0135" title="JonesP . NSAIDs in soft tissue injury: current practice vs. available evidence. Emergency Medicine Australasia1998;10(4):361.">Jones 1998</a>)) </p> </li> <li> <p>Days seven or more (pain expected to be minimal (<a href="./references#CD007789-bbs2-0135" title="JonesP . NSAIDs in soft tissue injury: current practice vs. available evidence. Emergency Medicine Australasia1998;10(4):361.">Jones 1998</a>), and analgesics often stopped (<a href="./references#CD007789-bbs2-0140" title="KellettJ . Acute soft tissue injuries – a review of the literature. Medicine and Science in Sports and Exercise1986;18(5):489-500. [PMID: 3534506]">Kellett 1986</a>)) </p> </li> </ul> </p> </section> </section> </section> <section id="CD007789-sec-0040"> <h5 class="title">Secondary outcomes</h5> <section id="CD007789-sec-0041"> <h6 class="title">Swelling</h6> <p>We intended to combine trials that reported swelling using an objective measure, such as water displacement in mL, or circumference in cm (mean with SD given or calculable), in a meta‐analysis using the standardised mean difference (SMD, 95% CI). If trials reported subjective reduction in swelling, we treated this as dichotomised data. </p> <p>We aimed to assess swelling at the following time points.</p> <p> <ul id="CD007789-list-0005"> <li> <p>Day zero to three (bleeding due to initial tissue trauma)</p> </li> <li> <p>Days four to six (maximum inflammatory response – data from animal studies)</p> </li> <li> <p>Day seven or more (resolution of swelling in most cases)</p> </li> </ul> </p> </section> <section id="CD007789-sec-0042"> <h6 class="title">Function</h6> <p>Where available, we presented data from self‐reported assessment of function and activities of daily living. However, the included trials usually reported function as 'Time to return of function' (from the time of injury to the time to return to full activity (work or sports)) and 'Functional impairment'. We dichotomised functional impairment on categorical scales, considering none or slightly clinically successful, and reported risk ratios (95% CI). If measured on a VAS, we calculated mean differences (95% CI). We took a difference of 15 mm to represent a clinically significant difference. We assessed 'Time to return to function' where possible, as proportions of people who had returned to function at the prespecified time intervals below. </p> <p> <ul id="CD007789-list-0006"> <li> <p>Up to day seven</p> </li> <li> <p>Days 7 to 14</p> </li> <li> <p>After day 14</p> </li> </ul> </p> </section> <section id="CD007789-sec-0043"> <h6 class="title">Adverse effects</h6> <p>We tabulated the presence or absence of major and minor adverse outcomes (described above) that occurred any time within three months (90 days) of the start of the study. We calculated risk ratios (95% CI). </p> </section> <section id="CD007789-sec-0044"> <h6 class="title">Re‐injury</h6> <p>We intended to calculate risk ratios (95% CI) for the proportion of participants who reported that they had a recurrence of the index injury within three months. We planned to assess time to re‐injury, where possible, as the proportions of people who had re‐injured within the prespecified time intervals (up to day 15, days 15 to 30, after day 30); however, we found that included studies, or those retrieved for full text review, reported this outcome. </p> </section> </section> </section> <section id="CD007789-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>We did not include cluster‐randomised or cross‐over trials, a decision that minimised the unit of analyses issues in this review. We stratified analysis by different time points, to avoid the effect modification of time with respect to the outcomes measured. Some studies reported adverse effects at the event level rather than the participant level (some participants may have had more than one adverse event in the same system). We included data at the participant level, rather than the event level, in the analysis. </p> <section id="CD007789-sec-0046"> <h5 class="title">Multiple interventions</h5> <p>For trials investigating multiple interventions (for example, NSAID 1 versus NSAID 2 versus other analgesic), we combined the groups for comparison into a single pair‐wise comparison for the meta‐analysis (thus, NSAID 1 and NSAID 2 versus other analgesic), as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007789-bbs2-0128" title="HigginsJPT , DeeksJJ , AltmanDG . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011a</a>). </p> </section> </section> <section id="CD007789-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>At the study level, we tried to ensure that we found all relevant studies by using a comprehensive search strategy. From study authors, we sought outcome data that studies measured but did not report. Where possible, we calculated missing standard deviations from other data, such as standard errors, exact P values, and 95% confidence intervals, when presented in the trial reports. Had we imputed data from other sources, we intended to perform a sensitivity analysis, by calculating the treatment effect including and excluding the imputed data, to see whether this would alter the outcome of the analysis. </p> <p>Where studies reported adverse events at the event level for the broad categories of gastrointestinal and neurological adverse events, we used participant‐level data for the most common adverse event within the broad categories in the analysis. </p> </section> <section id="CD007789-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We displayed the results graphically, using forest plots with a summary statistic, in the absence of major clinical or statistical heterogeneity (lack of overlap of confidence intervals on the forest plots; <a href="./references#CD007789-bbs2-0103" title="EggerM , DickersinK , Davey-SmithG . Chapter 3: Problems and limitations in conducting systematic reviews. In: EggerM , SmithGD , AltmanDG , editors(s). Systematic Reviews in Healthcare: Meta-analysis in Context. 2nd edition. London: BMJ, 2001:43-65.">Egger 2001</a>; <a href="./references#CD007789-bbs2-0104" title="EggerM , SmithGD . Chapter 2: Principles and procedures for systematic reviews. In: EggerM , SmithGD , AltmanDG , editors(s). Systematic Reviews in Healthcare: Meta-analysis in Context. London: BMJ, 2001:23-42.">Egger 2001a</a>). We assessed heterogeneity between trial results by examining the forest plots and calculating I² and Chi² statistics (<a href="./references#CD007789-bbs2-0126" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [PMID: 12958120]">Higgins 2003</a>). </p> </section> <section id="CD007789-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess reporting bias, using funnel plots when a single comparison included 10 or more studies (<a href="./references#CD007789-bbs2-0129" title="SterneJAC , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011b</a>). </p> </section> <section id="CD007789-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We combined data using standard inverse variance methods and a fixed‐effect model.</p> </section> <section id="CD007789-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We undertook subgroup analysis where there was disparity in the dosing of the drugs under comparison (e.g. one drug was given at standard dose and the other was given at less than standard dose): </p> <p> <ul id="CD007789-list-0007"> <li> <p>insufficient dosing (less than maximum dose) of at least one comparator drug or relative dose discrepancy between comparators (i.e. one drug at low dose of therapeutic range and the other at maximal dose) versus </p> </li> <li> <p>equivalent dosing of all comparator drugs (defined by national formulary of country of study, or British National Formulary, if this was not available). </p> </li> </ul> </p> <p>Where there were sufficient numbers of trials, we undertook subgroup analysis by the analgesic comparator (paracetamol, opioid, paracetamol plus opioid). </p> <p>We used the test for subgroup differences available in Review Manager 5 for the fixed‐effect model, to determine if the results for subgroups were conclusive (<a href="./references#CD007789-bbs2-0178" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). </p> <p>Where possible in future, we plan to undertake subgroup analyses based on NSAID categories (COX‐2 selective versus non‐selective NSAIDs), and age (&lt; 18 years, 18 to 65 years, and &gt; 65 years). </p> </section> <section id="CD007789-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>We undertook sensitivity analyses to explore the effects of different risks of bias associated with sequence generation (low or unclear versus high), allocation concealment (low or unclear versus high), and blinding (low versus unclear or high). </p> </section> <section id="CD007789-sec-0053"> <h4 class="title">'Summary of findings' tables</h4> <p>We summarised the results for the three comparisons for which there were data in 'Summary of findings' tables: NSAIDs versus paracetamol, NSAIDs versus opioid, and NSAIDs versus paracetamol plus opioid. We used the GRADE approach to assess the certainty of evidence related to seven key outcomes for each comparisons (<a href="./references#CD007789-bbs2-0185" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlaziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Schünemann 2011</a>). We used GRADEpro GDT to create the 'Summary of findings' tables and imported them into Review Manager 5 (<a href="./references#CD007789-bbs2-0117" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 13 May 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). </p> <p>The outcomes were pain at &lt; 24 hours; pain at 1 to 3 days (or 4 to 6 days if not available); pain at day 7 or later; swelling at day 7 or later; return to function at day 7 or later; gastrointestinal adverse events; and neurological adverse events. Although no studies reported on early re‐injury, we retained this as a key outcome, despite this increasing the number of outcomes to eight. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007789-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007789-sec-0054"></div> <section id="CD007789-sec-0055"> <h3 class="title">Description of studies</h3> <section id="CD007789-sec-0056"> <h4 class="title">Results of the search</h4> <p>For this update, we screened a total of 4353 records from the following databases: CENTRAL (854), MEDLINE (518), Embase (675), CINAHL (125), AMED (44), SPORTDiscus (48), International Pharmaceutical Abstracts (51), PEDro (444), the WHO ICTRP (621), and ClinicalTrials.gov (973). We searched CENTRAL, MEDLINE, and Embase to January 2020, and the other databases to February 2019. Our searches of other resources (reference lists) identified no additional studies that appeared to meet the inclusion criteria. </p> <p>Once duplicates had been removed, we had a total of 2419 records. Two studies changed status since the previous version of this review. The PanAM study, which was ongoing in 2015, was published as <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>, and 'Graham 2012', previously awaiting classification, has been published as <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>. </p> <p>We included four new trials <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>, in addition to the previously included 16 trials (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). We excluded another 50 studies (see <a href="./references#CD007789-bbs1-0002" title="">Excluded studies</a>), two studies are ongoing (see <a href="./references#CD007789-bbs1-0004" title="">Ongoing studies</a>), and two are awaiting classification (see <a href="./references#CD007789-bbs1-0003" title="">Studies awaiting classification</a>). </p> <p><a href="#CD007789-fig-0001">Figure 1</a> illustrates details of the process of screening and selecting studies for inclusion in the review (including the database search results from the previous publication; <a href="./references#CD007789-bbs2-0202" title="JonesP , DalzielSR , LamdinR , Miles-ChanJL , FramptonC . Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database of Systematic Reviews2015, Issue 7. Art. No: CD007789. [DOI: 10.1002/14651858.CD007789.pub2]">Jones 2015</a>). </p> <div class="figure" id="CD007789-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram for update" data-id="CD007789-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for update</p> </div> </div> </div> <section id="CD007789-sec-0057"> <h5 class="title">Results of contacting authors</h5> <p>We attempted to contact trialists when we needed clarification on study eligibility criteria for the review, or published data were insufficient to include in the quantitative analysis. We considered the published data sufficient for inclusion in just one included study (<a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>). We were unable to find current contact details for four included studies (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>), and two excluded studies (<a href="./references#CD007789-bbs2-0022" title="BuccellettiF , MarsilianiD , ZuccalaG , IacominiP , ProiettiL , PolaE , et al. Paracetamol-codeine compared to ketorolac for pain control in the emergency department. European Review for Medical and Pharmacological Sciences2014;18(20):3139-43. ">Buccelletti 2014</a>; <a href="./references#CD007789-bbs2-0030" title="De GaraC , TaylorM , HedgesA . Assessment of analgesic drugs in soft tissue injuries presenting to an accident and emergency department – a comparison of antrafenine, paracetamol and placebo. Postgraduate Medical Journal1982;58(682):489-92. [PMID: 6752926]">De Gara 1982</a>). We received no reply from authors of six included studies (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>). We received replies from authors of eight included studies, five of whom provided the requested data (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>), and three who reported that the study data were no longer available (<a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). Notably, we received adverse events data from <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> subsequent to the finalisation of the 2015 version of this review; we added these data to the current version (2020). We received replies from authors of two excluded studies, <a href="./references#CD007789-bbs2-0046" title="Le MayS , GouinS , FortinC , MessierA , RobertMA , JulienM . Efficacy of an ibuprofen/codeine combination for pain management in children presenting to the emergency department with a limb injury: a pilot study. Journal of Emergency Medicine2013;44(2):536-42. [PMID: 23232154]Le MayS . Request for data relevant to this review [personal communication]. Email to: P Jones 6 September 2013. LeMayS , GouinS , RobertMA , MessierA , MorinN . Combination of analgesics for pain management of children presenting to the emergency department for an acute musculoskeletal trauma. Academic Emergency Medicine2010;17:S142. NCT01189773. Combined analgesia to control pain in children seen in emergency department for a trauma of a limb. clinicaltrials.gov/ct2/show/NCT01189773 (first received 27 August 2010). ">Le May 2013</a> provided data, while <a href="./references#CD007789-bbs2-0068" title="YatesD . Request for data relevant to this review [personal communication]. Email to: P Jones October 2011. YatesDW , LaingGS , PetersK , KumarK . Mild analgesics and the accident and emergency department – cost and safety more important than potency?Archives of Emergency Medicine1984;1(4):197-203. [PMID: 6399444]">Yates 1984</a> reported that the study data were no longer available. We had contacted one pharmaceutical company previously, but they did not provide data relevant to this review (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>). </p> </section> </section> <section id="CD007789-sec-0058"> <h4 class="title">Included studies</h4> <p>The 20 trials included a total of 3305 participants, 3287 for whom data were available for at least one outcome. For each trial, we present a summary of the condition, comparison, number randomised, number analysed for the outcome 'pain', and the number included in at least one outcome <a href="#CD007789-tbl-0004">Table 1</a>. Participants of seven trials had acute ankle sprains, and those of <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a> had either ankle or wrist sprains. The participants of the other 12 trials were being treated for a variety of conditions; these were either solely or mainly soft tissue injuries. In all except one study, it was clear or likely that the majority of participants had an acute soft tissue injury. <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a> did not state this explicitly, and <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a> did not specify that 'acute' was &lt; 48 hours; however, as the setting was an emergency department in both studies, we considered it most likely that this was the case. We provide a full description of individual studies in the <a href="./references#CD007789-sec-0174" title="">Characteristics of included studies</a> table. </p> <div class="table" id="CD007789-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of key characteristics of the included trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Condition^</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No. randomised</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No. in analyses (pain)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No. in analyses (at least<br/>1 outcome)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (76%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (70%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children: Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol<br/>NSAID vs opioid </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children: ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acute soft tissue injury (&gt;80%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acute soft tissue injury (86%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>519</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (and back pain)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle/wrist sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children: Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (92%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acute soft tissue injury (96%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>365</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (82%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>206</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TOTAL</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 = ankle (+ 1 wrist) sprain. Others included any</p> <p>acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 'vs paracetamol'<br/>6 'vs opioid'<br/>4 'vs combined' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2908</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3287</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>^notes in brackets reflect trials in which a percentage of the population met the review inclusion criteria<br/>*combined = paracetamol plus opioid<br/>vs = versus </p> </div> </div> <p>Five studies had three trial groups (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>). The third group in three studies, <a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>, <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>, and <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>, used a combination intervention of NSAID plus paracetamol, and <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a> used a combination of NSAID plus opioid; we excluded these four groups from the review. <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> compared ibuprofen versus paracetamol versus codeine. </p> <p><a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006,</a><a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>, and <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a> had four treatment groups; valdecoxib twice daily, valdecoxib once daily, tramadol, and placebo in <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; and indomethacin, diclofenac, paracetamol, and a combination of diclofenac plus paracetamol in <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a> and <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>. We merged data from the first two NSAID groups in the analyses for all three trials, and excluded the fourth group, either placebo or a combination of NSAID plus paracetamol, from all three trials. </p> <p>We grouped the following description of studies by the comparisons listed in <a href="#CD007789-sec-0019">Types of interventions</a>. There were no trials comparing NSAID versus complementary and alternative medicine. Note that <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> features in two comparisons: NSAID versus paracetamol, and NSAID versus opioid. </p> <section id="CD007789-sec-0059"> <h5 class="title">NSAID versus paracetamol</h5> <p>Eleven studies compared NSAID with paracetamol (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). Data were available for analysis of at least one outcome for 1843 out of 1853 participants; <a href="#CD007789-tbl-0004">Table 1</a>. </p> <p>One study received no funding (<a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>); two studies were sponsored by pharmaceutical companies (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>); four studies were funded through competitive public good research grants (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>); and four studies did not state the source of funding (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>). An author of one study was an employee of a pharmaceutical company (<a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>); the authors of five studies declared no relevant interests (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>); and five studies made no statement of declaration of interests (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). </p> <p>Four studies, with 530 participants, studied exclusively ankle sprain (<a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>). The other seven studies included a mix of participants with mainly lower and upper extremity soft tissue injuries (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). Due to variable reporting in the studies, it was not possible to account for the exact numbers of participants with specific injuries in these studies; these included at least 77 participants with back or neck injuries, 66 with lacerations, and 70 with minor fractures (which were initially thought to be soft tissue injuries); injuries that were outside the criteria for the review, but whose data we were unable to disaggregate for analysis. Thus, we included the data from these participants (approximately 11%) in the review. </p> <p>All studies reported the gender of the enrolled participants; 60% of participants were male. Participants of two studies (N = 152) were exclusively children aged 6 to 17 years (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>), and 8 to 14 years (<a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>), with the remaining nine studies conducted exclusively in adults over 16 years of age. Two studies (N = 320), in which 80% of participants were white, reported ethnicity (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>). </p> <p>The studies took place in Canada (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>); Greece (<a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>); Hong Kong (<a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>); Turkey (<a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>); the United Kingdom (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>); the Netherlands (<a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>); and the USA (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>). The studies were carried out in a variety of locations, including general practice, emergency departments, student health centres, research facilities, sports medicine clinics, orthopaedic clinics, urgent care facilities, and rheumatology clinics. </p> <p>Five studies compared ibuprofen with paracetamol (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>); one compared naproxen with paracetamol (<a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>); three compared diclofenac with paracetamol (<a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>); and two separate studies, by the same group, compared indomethacin and diclofenac separately with paracetamol (<a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). The doses of the medications varied across the studies. Submaximal dosing of paracetamol occurred in three studies (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>); and submaximal dosing of NSAID was present in two studies (<a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). In <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>, the initial dose was optimal for the analysis in the emergency department, but subsequent daily dosing was suboptimal. </p> <p>All but one study reported suitable data for pain (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>); three studies provided suitable data about swelling (<a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>); two provided suitable data on function (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>); and 10 studies provided suitable data on adverse events for the meta‐analysis (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). </p> </section> <section id="CD007789-sec-0060"> <h5 class="title">NSAID versus opioid</h5> <p>Six studies compared NSAIDs with opioids (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). Data were available for analysis for at least one outcome for 1205 out of 1212 participants (<a href="#CD007789-tbl-0004">Table 1</a>). </p> <p>One study received no funding (<a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>); one was funded by a pharmaceutical company (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>); two were funded through competitive public good research grants (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>); and two studies did not state the source of funding (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). An author of one study was an employee of a pharmaceutical company (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>); the authors of three studies stated no relevant interests (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>); and two studies made no statement of declarations of interest (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). </p> <p>Two studies, with 792 participants, exclusively considered ankle sprain (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a> included participants with a mixture of lower extremity (53 participants) and 'other' sites (10 participants) of soft tissue injury. <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a> included 150 participants with a mix of injury types, including 26 with lumbosacral or intervertebral disc problems. <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> did not specify the site or type of injury. The study authors of <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>, which included approximately 40% fractures, provided data to us on the 134 participants with soft tissue injuries in multiple sites separately for inclusion in this review. </p> <p>Five of the studies reported the gender of participants. Slightly under 60% were male (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>). <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> reported no difference in the ratio of male and female, but provided no data. Two of the studies (N = 202) randomised exclusively children aged 6 to 17 years (mean age of 12 years; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>), one of which only enrolled participants during the approximately 30 hours per week when research staff were available (<a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>). One study enrolled participants aged between 16 and 64 years, with a mean age of 29 years (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>); one enrolled participants aged between 18 and 45 years (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>); and one study enrolled participants older than 18 years, with no upper age limit (<a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>). One did not state an age restriction; the mean age of those enrolled in this study was 32 years (<a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). Only <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> reported ethnicity of participants; 80% were white, 8% black, 3% Asian, and 9% other. </p> <p>Three of the studies were single‐centre emergency department studies: one in the United Kingdom (<a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>), one in Canada (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>), and one in Iran (<a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>). Another Canadian study was a multicentre emergency department study (<a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>). The study by <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a> took place at a football club in the United Kingdom. <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> was a multicentre study with 14 European and 73 American sites; it did not state whether these were hospital‐based, emergency or orthopaedic departments, or primary care facilities. </p> <p>Three studies compared naproxen with dextropropoxyphene (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>), dihydrocodeine (<a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>), and oxycodone (<a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> reported a four‐arm factorial trial, simultaneously comparing plaster immobilisation to Tubigrip™ bandage, as well as NSAID versus opioid. <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> compared ibuprofen with codeine phosphate, and <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a> compared ibuprofen to morphine. <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> compared two doses of valdecoxib (selective COX‐2 inhibitor) separately with tramadol. Submaximal dosing of tramadol was present in one study (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>). </p> <p>Four studies reported data sufficiently to be pooled for the outcome of pain (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>), one reported swelling (<a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>), two reported on function (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>), and four reported adverse events (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>). </p> </section> <section id="CD007789-sec-0061"> <h5 class="title">NSAID versus combination analgesics (combination of paracetamol and opioid)</h5> <p>Four studies compared NSAIDs with combined analgesics (paracetamol and an opioid; <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>). Data were available for analysis for at least one outcome for 239 out of 240 participants (<a href="#CD007789-tbl-0004">Table 1</a>). </p> <p>Two studies were funded by pharmaceutical companies (<a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>); two did not state the source of funding (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>). An author of one study was an employee of a pharmaceutical company (<a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>); the other three studies made no statement of declarations of interest.<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>). </p> <p><a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a> studied only ankle sprains; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>studied ankle or wrist injuries; and there was a mix of injuries in the remaining two studies (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>). In total, 25 participants had ankle injuries; 25 had other lower extremity injuries; 37 had upper extremity injuries; and for 12 participants, the site was not specified. Some participants in two studies had back injuries or inflammatory conditions that were outside the criteria for the review (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>). Since separate outcome data for eligible participants were not available, we included the data from these participants (approximately 15% of study populations) in the review (<i>see</i><a href="#CD007789-sec-0162">Differences between protocol and review</a>). </p> <p>All studies referred to the gender of the enrolled participants: 72% were male. The age range of participants was 16 years to 66 years. No study reported ethnicity data. </p> <p>The studies took place in the UK (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>), and the USA (<a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>). The studies were carried out in a variety of centres, including general practice, emergency departments, armed forces medical centres, and university sports clinics. </p> <p>Two studies compared NSAIDs with a combination of paracetamol and dextropropoxyphene. The NSAID was diflunisal in <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>, and naproxen in <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>. The other two studies compared a single NSAID (diflunisal) versus a paracetamol and codeine combination (<a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>). The doses of the medications varied across the studies. All studies used combination analgesics that contained submaximal doses of paracetamol. </p> <p>We included three of the four studies in the pain analyses (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>). Data from <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a> were unavailable for analysis because of the way in which the results were reported (for example, no standard deviations were reported for continuous outcomes, and we were unable to obtain separate data for acute soft tissue injuries). For similar reasons, we included data from <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> only in the analyses for swelling and function. We pooled data on adverse events from all four studies. </p> </section> </section> <section id="CD007789-sec-0062"> <h4 class="title">Excluded studies</h4> <p>We grouped the 50 excluded studies initially by comparison, then by condition studied, and trial design. We provide more details of the reasons for excluding the studies in the '<a href="./references#CD007789-sec-0175" title="">Characteristics of excluded studies</a>' table. </p> <section id="CD007789-sec-0063"> <h5 class="title">NSAID versus paracetamol</h5> <p>Five mixed population studies reported insufficiently separate data on relevant participants (<a href="./references#CD007789-bbs2-0022" title="BuccellettiF , MarsilianiD , ZuccalaG , IacominiP , ProiettiL , PolaE , et al. Paracetamol-codeine compared to ketorolac for pain control in the emergency department. European Review for Medical and Pharmacological Sciences2014;18(20):3139-43. ">Buccelletti 2014</a>; <a href="./references#CD007789-bbs2-0030" title="De GaraC , TaylorM , HedgesA . Assessment of analgesic drugs in soft tissue injuries presenting to an accident and emergency department – a comparison of antrafenine, paracetamol and placebo. Postgraduate Medical Journal1982;58(682):489-92. [PMID: 6752926]">De Gara 1982</a>; <a href="./references#CD007789-bbs2-0047" title="Le ParcJM , Van GanseE , MooreN , WallR , SchneidH , VerrièreF . Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients. Clinical Rheumatology2002;21(1):28-31. [PMID: 11954880]MooreN , CharlesworthA , Van GanseE , LeParcJM , JonesJK , WallR , et al. Risk factors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiology and Drug Safety2003;12(7):601-10. [PMID: 14558184]MooreN , Van GanseE , Le ParcJM , WallR , SchneidH , FarhanM , et al. The PAIN study: Paracetamol, Aspirin and Ibuprofen New tolerability study. A large-scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clinical Drug Investigation1999;18(2):89-98. MooreN . Forty years of ibuprofen use. International Journal of Clinical Practice Supplement2003;135:28-31. [PMID: 12723744]">Moore 1999</a>; <a href="./references#CD007789-bbs2-0058" title="PatelR . Management of painful inflammatory disorders in paediatric practice. Indian Practitioner1993;46(7):513-20. ">Patel 1993</a>; <a href="./references#CD007789-bbs2-0068" title="YatesD . Request for data relevant to this review [personal communication]. Email to: P Jones October 2011. YatesDW , LaingGS , PetersK , KumarK . Mild analgesics and the accident and emergency department – cost and safety more important than potency?Archives of Emergency Medicine1984;1(4):197-203. [PMID: 6399444]">Yates 1984</a>). We attempted to contact study authors for additional information. One author replied (<a href="./references#CD007789-bbs2-0068" title="YatesD . Request for data relevant to this review [personal communication]. Email to: P Jones October 2011. YatesDW , LaingGS , PetersK , KumarK . Mild analgesics and the accident and emergency department – cost and safety more important than potency?Archives of Emergency Medicine1984;1(4):197-203. [PMID: 6399444]">Yates 1984</a>); however, the original study data were no longer available. One study, <a href="./references#CD007789-bbs2-0070" title="NCT03428503. Comparison of efficacy of intravenous paracetamol and dexketoprofen for acute traumatic musculoskeletal pain. clinicaltrials.gov/ct2/show/NCT03428503 (first received 09 February 2018). YilmazA , SabirliR , OzenM , TurkcuerI , ErdurB , ArikanC , et al. Intravenous paracetamol versus dexketoprofen in acute musculoskeletal trauma in the emergency department: a randomised clinical trial. American Journal of Emergency Medicine2019;37(5):902-8. ">Yilmaz 2019</a>, reported intravenous dosing of NSAIDs and paracetamol; a route that was not specified for this review . </p> </section> <section id="CD007789-sec-0064"> <h5 class="title">NSAID versus opioid</h5> <p>One study reported insufficiently separate data for participants with relevant injuries (<a href="./references#CD007789-bbs2-0057" title="PagliaraL , TornagoS , MetastasioJ , PerettiG , AlbisettiW , ThovezG , et al. Tramadol compared with diclofenac in traumatic musculoskeletal pain. Current Therapeutic Research, Clinical and Experimental1997;58(8):473-80. ">Pagliara 1997</a>); the authors did not respond to a request for data. One study enrolled the majority of participants after 48 hours of injury (<a href="./references#CD007789-bbs2-0036" title="GoswickC . Ibuprofen versus propoxyphene hydrochloride and placebo in acute musculoskeletal trauma. Current Therapeutic Research, Clinical and Experimental1983;34(4):685-92. ">Goswick 1983</a>). </p> </section> <section id="CD007789-sec-0065"> <h5 class="title">NSAID versus combination analgesics (combination of paracetamol and opioid)</h5> <p>One study was not randomised (<a href="./references#CD007789-bbs2-0064" title="StableforthPG . Mefenamic acid and dextropropoxyphene with paracetamol as analgesics in the accident department. Current Medical Research and Opinion1977;5(2):189-91. [PMID: 340138]">Stableforth 1977</a>); we were unable to disaggregate data for participants with relevant injuries in the other six studies (<a href="./references#CD007789-bbs2-0022" title="BuccellettiF , MarsilianiD , ZuccalaG , IacominiP , ProiettiL , PolaE , et al. Paracetamol-codeine compared to ketorolac for pain control in the emergency department. European Review for Medical and Pharmacological Sciences2014;18(20):3139-43. ">Buccelletti 2014</a>; <a href="./references#CD007789-bbs2-0039" title="HardoHG , TempletonJS . A short-term randomised comparative study of Rheumox and distalgesic in outpatients suffering from painful soft tissue injuries/sprains and strains. British Journal of Clinical Practice1982;36:112-5. ">Hardo 1982</a>; <a href="./references#CD007789-bbs2-0048" title="Muncie HL Jr, KingDE , DeForgeB . Treatment of mild to moderate pain of acute soft tissue injury: diflunisal vs acetaminophen with codeine. Journal of Family Practice1986;23(2):125-7. [PMID: 2942630]">Muncie 1986</a>; <a href="./references#CD007789-bbs2-0061" title="SherryE , JackD , HendersonA . Post-traumatic pain relief on an out-patient basis: drug trial looking at injured skiers. Australian Journal of Science and Medicine in Sport1988;20(1):18-20. ">Sherry 1988</a>; <a href="./references#CD007789-bbs2-0062" title="SimmonsRL , OwenS , AbbottCJ , Bouchier-HayesTA , HuntHA . Naproxen sodium and paracetamol/dextropropoxyphene in sports injuries – a multicentre comparative study. British Journal of Sports Medicine1982;16(2):91-5. [PMID: 7104563]">Simmons 1982</a>; <a href="./references#CD007789-bbs2-0063" title="SleetRA , KhanMA . Comparative study of mefenamic acid and dextropropoxyphene plus paracetamol in an accident and emergency department. Current Medical Research and Opinion1980;7(2):77-84. [PMID: 7438771]">Sleet 1980</a>). The study authors did not respond to requests for more data. </p> </section> <section id="CD007789-sec-0066"> <h5 class="title">NSAID plus other analgesic versus NSAID alone</h5> <p>Four studies (<a href="./references#CD007789-bbs2-0044" title="KolodnyAL , Winter L Jr. Further clinical evaluations of nefopam hydrochloride, a new analgesic. Current Therapeutic Research, Clinical and Experimental1975;17(6):519-24. [PMID: 808373]">Kolodny 1975</a>; <a href="./references#CD007789-bbs2-0046" title="Le MayS , GouinS , FortinC , MessierA , RobertMA , JulienM . Efficacy of an ibuprofen/codeine combination for pain management in children presenting to the emergency department with a limb injury: a pilot study. Journal of Emergency Medicine2013;44(2):536-42. [PMID: 23232154]Le MayS . Request for data relevant to this review [personal communication]. Email to: P Jones 6 September 2013. LeMayS , GouinS , RobertMA , MessierA , MorinN . Combination of analgesics for pain management of children presenting to the emergency department for an acute musculoskeletal trauma. Academic Emergency Medicine2010;17:S142. NCT01189773. Combined analgesia to control pain in children seen in emergency department for a trauma of a limb. clinicaltrials.gov/ct2/show/NCT01189773 (first received 27 August 2010). ">Le May 2013</a>; <a href="./references#CD007789-bbs2-0065" title="TurturroMA , FraterCR , D'AmicoFJ . Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial. Annals of Emergency Medicine2003;41(6):818-26. [PMID: 12764337]">Turturro 2003</a>; <a href="./references#CD007789-bbs2-0069" title="IRCT138904014238N1. Effect of oral and intramuscular injection of methocarbamol and placebo on muscle strain [Comparison effect of oral and intramuscular injection of methocarbamol and placebo on muscle strain]. apps.who.int/trialsearch/trial.aspx?trialid=IRCT138904014238N1 (first received 10 October 2010). [IRCT138904014238N1]YazdanpanahP , NikbakhtS , KheraminS , HossiniR . Effect of oral and intramuscular injection of methocarbamol and placebo on muscle strain pain. European Journal of Pain Supplements2011;5(1):26. ">Yazdanpanah 2011</a>), and one ongoing study (<a href="./references#CD007789-bbs2-0054" title="NCT03025113. Efficacy and safety of the combination of ketoprofen and cyclobenzaprine in osteomuscular treatment. clinicaltrials.gov/ct2/show/NCT03025113 (first received 19 January 2017). ">NCT03025113</a>) compared a combination of NSAID plus another oral analgesic agent with NSAID alone; <a href="./references#CD007789-bbs2-0044" title="KolodnyAL , Winter L Jr. Further clinical evaluations of nefopam hydrochloride, a new analgesic. Current Therapeutic Research, Clinical and Experimental1975;17(6):519-24. [PMID: 808373]">Kolodny 1975</a> was also not randomised. </p> </section> <section id="CD007789-sec-0067"> <h5 class="title">NSAID plus other analgesic versus combination analgesics</h5> <p>We excluded two studies (<a href="./references#CD007789-bbs2-0026" title="ChangAK , BijurPE , EssesD , BarnabyDP , BaerJ . Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: a randomized clinical trial. JAMA2017;318(17):1661-7. NCT02455518. Comparative efficacy of 4 oral analgesics. clinicaltrials.gov/ct2/show/NCT02455518 (first received 28 May 2015). ">Chang 2017</a>; <a href="./references#CD007789-bbs2-0037" title="GraudinsA , MeekR , ParkinsonJ , Egerton-WarburtonD , MeyerA . A randomised controlled trial of paracetamol and ibuprofen with or without codeine or oxycodone as initial analgesia for adults with moderate pain from limb injury. Emergency Medicine Australasia2016;28(6):666-72. ">Graudins 2016</a>), and three ongoing studies that compared NSAIDs in combination with another analgesic agent with different combinations of analgesic agents (<a href="./references#CD007789-bbs2-0053" title="NCT02862977. Efficacy and safety of the combination of ketoprofen and cyclobenzaprine and caffeine in osteomuscular treatment. clinicaltrials.gov/ct2/show/NCT02862977 (first received 11 August 2016). ">NCT02862977</a>; <a href="./references#CD007789-bbs2-0055" title="NCT03173456. Comparing five oral analgesics for treatment of acute pain in the ED. clinicaltrials.gov/ct2/show/NCT03173456 (first received 01 June 2017). ">NCT03173456</a>; <a href="./references#CD007789-bbs2-0056" title="NCT03767933. Non-steroidal or opioid analgesia use for children with musculoskeletal injuries. clinicaltrials.gov/ct2/show/NCT03767933 (first received 07 December 2018). ">NCT03767933</a>). </p> </section> <section id="CD007789-sec-0068"> <h5 class="title">COX‐2 selective NSAID versus non‐selective NSAID</h5> <p>We excluded 10 studies comparing a COX‐2 selective NSAID with a non‐selective NSAID, because they did not compare an NSAID versus another oral analgesic agent (<a href="./references#CD007789-bbs2-0024" title="Cardenas-EstradaE , OliveiraLG , AbadHL , ElayanF , KhalifaN , El-HusseiniT . An open label randomized multicenter comparative study on celecoxib efficacy and safety versus non-selective NSAIDs in acute pain due to ankle sprain. Journal of International Medical Research2009;37(6):1937-51. NCT00446797. Open label randomized multicenter comparative study on celecoxib efficacy and safety versus non-selective NSAIDs in acute pain due to ankle sprain. clinicaltrials.gov/show/NCT00446797 (first received 13 March 2009). Pfizer Inc. A3191332. An open label randomized multicenter comparative study on celecoxib efficacy and safety versus non-selective NSAIDs in acute pain due to ankle sprain. www.clinicalstudyresults.org/documents/company-study (accessed 28 January 2009). ">Cardenas‐Estrada 2009</a>; <a href="./references#CD007789-bbs2-0025" title="CauchioliCA . Comparative trial between etodolac and naproxen in the treatment of acute sports injuries. Arquivo Brasileiro de Medicina1994;68(2):109-14. ">Cauchioli 1994</a>; <a href="./references#CD007789-bbs2-0029" title="D'HoogheM . Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries. Clinical Therapeutics1992;14(4):507-16. [PMID: 1388091]">D'Hooghe 1992</a>; <a href="./references#CD007789-bbs2-0031" title="DiazJA , CuervoC , ValderramaAM , KohlesJ . Valdecoxib provides effective pain relief following acute ankle sprain. Journal of International Medical Research2006;34(5):456-67. [PMID: 17133774]Pfizer Inc. Protocol VALA-0513-146. A multi-center, randomised, double-blind, parallel group study to compare the efficacy and tolerability of valdecoxib vs. diclofenac in ankle sprain. www.clinicalstudyresults.org/documents/company-study (accessed 27 April 2004). ">Diaz 2006</a>; <a href="./references#CD007789-bbs2-0033" title="EkmanEF , FiechtnerJJ , LevyS , FortJG . Efficacy of celecoxib versus ibuprofen in the treatment of acute pain: a multicenter, double-blind, randomized controlled trial in acute ankle sprain. American Journal of Orthopedics2002;31(8):445-51. [PMID: 12216965]">Ekman 2002</a>; <a href="./references#CD007789-bbs2-0035" title="FerreiraA , EspirandelliL , PelosoUC . Etodolac versus diclofenac in acute sports injuries [Etodolac versus diclofenaco em traumatismos esportivos agudos]. Arquivos Brasileiros de Medicina1992;66(2):175-81. [0365-0723]">Ferreira 1992</a>; <a href="./references#CD007789-bbs2-0041" title="JenoureP , GorschewskyO , RyfC , SteigbugelM , WetzelC , FreyW , et al. Randomised, double-blind, multicentre study of nimesulide vs. diclofenac in adults with acute sport injuries. Journal of Drug Assessment1998;1:495-508. ">Jenoure 1998</a>; <a href="./references#CD007789-bbs2-0049" title="CawkwellG . Success II-G study data [personal communication]. Email to: P Jones 19 August 2008. NadarajahA , AbrahanL , LauFL , HwangLJ , Fakir-BolteC . Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Singapore Medical Journal2006;47(6):534-42. [PMID: 6752024]">Nadarajah 2006</a>; <a href="./references#CD007789-bbs2-0059" title="PetrellaR , EkmanEF , SchullerR , FortJG . Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a double-blind, randomized controlled trial. Clinical Journal of Sport Medicine2004;14(4):225-31. [PMID: 5273528]">Petrella 2004</a>; <a href="./references#CD007789-bbs2-0060" title="Pfizer Inc. A multicenter, randomized, open-label, parallel group study to compare the efficacy and tolerability of valdecoxib versus ketorolac in ankle sprain. Pharmaceutical Research and Manufacturers of America Database of Study Synopses 23 September 2005. ">Pfizer 2005</a>). We excluded a further six studies considering this comparison for additional reasons (<a href="./references#CD007789-bbs2-0023" title="CalligarisA , ScaricabarozziI , VecchietL . A multicentre double-blind investigation comparing nimesulide and naproxen in the treatment of minor sport injuries. Drugs1993;46(Suppl 1):187-90. [PMID: 7506168]">Calligaris 1993</a>; <a href="./references#CD007789-bbs2-0028" title="CostaJRB , RehfeldtLCL , Da SilvaSAG . Traumatic sprains and strains. Prospective blind study to compare the efficacy and safety of nimesulide and diclofenac. Revista Brasileira de Medicina1995;52(4):366-8. ">Costa 1995</a>; <a href="./references#CD007789-bbs2-0032" title="DougadosM , Le HenanffA , LogeartI , RavaudP . Short-term efficacy of rofecoxib and diclofenac in acute shoulder pain: a placebo-controlled randomized trial. PLoS Clinical Trials2007;2(3):e9. [PMID: 17347681]">Dougados 2007</a>; <a href="./references#CD007789-bbs2-0040" title="JennerPN . Nabumetone in the treatment of skin and soft tissue injury. American Journal of Medicine1987;83(4B):101-6. [PMID: 3318420]">Jenner 1987</a>; <a href="./references#CD007789-bbs2-0045" title="KyleC , ZachariahJ , KinchH , EllisG , AndrewsC , AdekunleF . A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain. International Journal of Clinical Practice2008;62(11):1684-92. [PMID: 19143855]">Kyle 2008</a>; <a href="./references#CD007789-bbs2-0050" title="NCT00954785. Etoricoxib in acute ankle ligament sprains. clinicaltrials.gov/show/NCT00954785 (first received 07 August 2009). ">NCT00954785</a>). </p> </section> <section id="CD007789-sec-0069"> <h5 class="title">Placebo and other comparisons</h5> <p>We excluded two studies that compared NSAID with placebo (<a href="./references#CD007789-bbs2-0021" title="AnderssonS , FredinH , LindbergH , SanzenL , WestlinN . Ibuprofen and compression bandage in the treatment of ankle sprains. Acta Orthopaedica Scandinavica1983;54(2):322-5. ">Andersson 1983</a>; <a href="./references#CD007789-bbs2-0042" title="JørgensenFR , GøtzschePC , HeinP , JensenCM , NielsenBM , NielsenFM , et al. Naproxen (Naprosyn) and mobilization in the treatment of acute ankle sprains [Naproxen (Naprosyn) og mobilisering ved behandling af akut ankeldistorsion]. Ugeskrift for Laeger1986;148(21):1266-68. ">Jorgensen 1986</a>), and one non‐randomised study that compared a biologically active CAM with placebo (<a href="./references#CD007789-bbs2-0034" title="FeragalliB , IppolitoE , DugallM , CacchioM , BelcaroG , CesaroneMR , et al. Effectiveness of a novel boswellic acids delivery form (Casperome) in the management of grade II ankle sprains due to sport trauma – a registry study. European Review for Medical and Pharmacological Sciences2017;21(20):4726-32. ">Feragalli 2017</a>). One other study compared an opioid with another non‐NSAID analgesic; this study was also not randomised (<a href="./references#CD007789-bbs2-0043" title="KhouryM , CaspiS , StalnikowicsR , PelessE , RaiizmanE , SalamehS . Emergency department administration of oxycodone by nurses treating musculoskeletal pain: an observational prospective study. Israel Medical Association Journal2018;20(5):281-5. ">Khoury 2018</a>). </p> </section> <section id="CD007789-sec-0070"> <h5 class="title">Wrong condition</h5> <p>Two ongoing studies were excluded as they are not recruiting people with acute soft tissue injuries (<a href="./references#CD007789-bbs2-0051" title="NCT01974609. Narcotic vs. non-narcotic pain study protocol. clinicaltrials.gov/ct2/show/NCT01974609 (first received 01 November 2013). ">NCT01974609</a>; <a href="./references#CD007789-bbs2-0052" title="NCT02373254. NSAIDS versus opioids in acute SER II ankle fractures. clinicaltrials.gov/ct2/show/NCT02373254 (first received 26 February 2015). ">NCT02373254</a>). </p> </section> <section id="CD007789-sec-0071"> <h5 class="title">Not RCT</h5> <p>Five other studies were excluded as they were not randomised controlled trials (<a href="./references#CD007789-bbs2-0027" title="CollopyKT , KivlehanSM , SnyderSR . Managing unstable musculoskeletal injuries. EMS World2012;41(2):36-43. ">Collopy 2012</a>; <a href="./references#CD007789-bbs2-0038" title="GyerVF , GlosterA . Use of non-steroidal drugs for the treatment of sprains. Nursing Standard2012;26(25):30. ">Gyer 2012</a>; <a href="./references#CD007789-bbs2-0040" title="JennerPN . Nabumetone in the treatment of skin and soft tissue injury. American Journal of Medicine1987;83(4B):101-6. [PMID: 3318420]">Jenner 1987</a>; <a href="./references#CD007789-bbs2-0066" title="vanden BekeromMP . No difference in pain, swelling or function with NSAIDs compared with paracetamol for soft tissue injury. Evidence-based Nursing2016;19(1):21. ">van den Bekerom 2016</a>; <a href="./references#CD007789-bbs2-0067" title="WhiteheadPB . Oral NSAIDs versus other oral analgesic agents for acute soft tissue injury. International Journal of Evidence-based Healthcare2016;14(3):138-9. ">Whitehead 2016</a>) </p> </section> </section> <section id="CD007789-sec-0072"> <h4 class="title">Ongoing studies</h4> <p>We identified two ongoing studies comparing NSAID with paracetamol (<a href="./references#CD007789-bbs2-0073" title="NCT02667730. Correlation between acute analgesia and long-term function following ankle injuries. https://clinicaltrials.gov/ct2/show/NCT02667730 (first received 29 January 2016). ">NCT02667730</a>; <a href="./references#CD007789-bbs2-0074" title="NCT03222518. NSAIDs versus paracetamol versus paracetamol + NSAIDs in traumatic pain management. https://clinicaltrials.gov/ct2/show/NCT03222518 (first received 19 July 2017). ">NCT03222518</a>); see <a href="./references#CD007789-sec-0177" title="">Characteristics of ongoing studies</a> for further information. </p> </section> <section id="CD007789-sec-0073"> <h4 class="title">Studies awaiting classification</h4> <p>One trial comparing ibuprofen to another medication may have been completed in 2010, but we do not know the class of the comparator medication. Only the trial registration is available for this study (<a href="./references#CD007789-bbs2-0071" title="CTRI/2009/091/001067. An open label, randomized, parallel group, prospective, multicentre clinical trial for evaluation of efficacy and safety of IN-Pharm-002 in comparison with ibuprofen in adult patients wity acute painful soft tissue injury. ctri.nic.in/Clinicaltrials/showallp.php?mid1=1196&amp;EncHid=&amp;userName=CTRI/2009/091/001067 (registered on 17 February 2010). ">CTRI/2009/091/001067</a>). One trial that has not yet started recruiting plans to compare diclofenac with a plant extract for pain and adverse effects when treating acute muscle strain (<a href="./references#CD007789-bbs2-0072" title="TCTR20160126001. Efficacy and safety of extracted Prasaplai for relieving acute muscle strain. apps.who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160126001 (first received 25 January 2016). ">TCTR20160126001</a>); <i>see</i><a href="http://archie.cochrane.org/sections/documents/view?document=25229530330673949176100129130356&amp;format=REVMAN#CHARACTERISTICS_OF_AWAITING_STUDIES" target="_blank">Characteristics of studies awaiting classification</a>. </p> </section> </section> <section id="CD007789-sec-0074"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD007789-fig-0002">Figure 2</a> and <a href="#CD007789-fig-0003">Figure 3</a> summarise the risk of bias for the included studies. </p> <div class="figure" id="CD007789-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD007789-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> <div class="figure" id="CD007789-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD007789-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> </div> <section id="CD007789-sec-0075"> <h4 class="title">Allocation</h4> <p>All 20 studies were randomised, although only eleven described an adequate method of sequence generation (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). Eight studies did not state the method of sequence generation, so the risk of bias was unclear (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a> did not describe the method of sequence generation. We judged it at high risk of bias as "an attempt was made to pair the patients for site and type of injury"; and thus, it may have been a quasi‐randomised study. </p> <p>Eight studies reported adequate allocation concealment, with the use of sealed, opaque, or unmarked envelopes, or identical packaging (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>). One study reported the use of envelopes, but did not provide further details (<a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>), and one used envelopes, but the study tablets were not identical (<a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>). In these studies, and the eight studies that did not report the method of allocation concealment, we considered the risk of bias unclear (<a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). Given the pairing of participants for site and type of injury, <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a> clearly did not conceal allocation; thus, we judged it to be at high risk of selection bias. The other study at high risk for selection bias was <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>, as it was an open‐label study. </p> </section> <section id="CD007789-sec-0076"> <h4 class="title">Blinding</h4> <p>Eleven studies had adequate blinding of outcome assessors, participants, and treatment providers, and we judged them at low risk of performance and detection bias (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). We judged one study at low risk of bias for blinding of treatment providers and outcome assessors, although not for participants, as it did not blind them (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>). Two studies blinded only the participants (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>), and <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> only blinded the outcome assessors. Four studies did not state the method of blinding, and we considered these to be at unclear risk of bias (<a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>). <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a> was an open‐label design, and at high risk of bias for blinding. </p> </section> <section id="CD007789-sec-0077"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed attrition bias separately according to the specific outcomes specified in the protocol of the review. Fifteen studies were at low risk of attrition bias across all outcomes they measured (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>). <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a> was at low risk for three outcomes, but at unclear risk for swelling, because it did not present these data in a format that allowed accurate abstraction. <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a> was at low risk for the outcomes of pain and adverse effects in the emergency department; unclear for function, as this was not reported; and high for adverse effects at one month, as less than 50% were followed to this point. <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a> was at low risk for two outcomes, and unclear risk for adverse events, because of incomplete reporting of these. <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a> was at unclear risk of bias because of not reporting the follow‐up rate. One study was at high risk of bias because of a disproportionate and high dropout rate between the groups (<a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). </p> </section> <section id="CD007789-sec-0078"> <h4 class="title">Selective reporting</h4> <p>Fourteen studies were at low risk of reporting bias (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a> was at unclear risk because of the way it described adverse effects. We considered five studies to be at high risk, either for not reporting all prespecified outcomes at the prespecified time points (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>), or for selectively reporting only a proportion of adverse events (<a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>). </p> </section> <section id="CD007789-sec-0079"> <h4 class="title">Other potential sources of bias</h4> <p>We judged that the most likely other source of bias would be performance bias, reflecting imbalance between intervention groups in the use of concomitant physical (rest, ice, compression, elevation, splintage), or pharmacological therapies during the studies. We considered seven studies at low risk of other bias (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>). </p> <p>Reflecting either no or incomplete accounts of treatment other than the interventions, we judged 12 studies to be at unclear risk of other bias (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). We considered <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a> to be at high risk of other bias because of the imbalance in the use of rehabilitation therapy (exercises) between the intervention groups. </p> </section> </section> <section id="CD007789-sec-0080"> <h3 class="title" id="CD007789-sec-0080">Effects of interventions</h3> <p>See: <a href="./full#CD007789-tbl-0001"><b>Summary of findings 1</b> NSAID compared with paracetamol for acute soft tissue injury</a>; <a href="./full#CD007789-tbl-0002"><b>Summary of findings 2</b> NSAID compared with opioid for acute soft tissue injury</a>; <a href="./full#CD007789-tbl-0003"><b>Summary of findings 3</b> NSAID compared with combination (paracetamol and opioid) analgesic for acute soft tissue injury</a> </p> <p>In the following, the continuous outcome measure for pain is the visual analogue scale, scored 0 to 100 mm; higher scores equal greater pain. </p> <p>In the following, we avoided potential unit of analysis issues when studies reported adverse events at the event level for the broad categories of gastrointestinal and neurological adverse events, by using participants‐level data for the most common adverse event within these broad categories in the analysis. This pertained to data from four trials, two of which appeared in the 2015 version of the review (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>), and two of which are newly included (<a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>). When checking through the studies for this problem, we realised that <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a> reported adverse events by participant rather than by event, and rectified this error. </p> <section id="CD007789-sec-0081"> <h4 class="title">NSAID versus paracetamol</h4> <p>Eleven studies (1853 participants) compared NSAID with paracetamol (<a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a>; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). </p> <section id="CD007789-sec-0082"> <h5 class="title">Pain</h5> <p>There is high‐certainty evidence of no clinically important difference between NSAID and paracetamol in pain measured for up to two hours (mean difference (MD) ‐0.12 mm, 95% CI ‐2.27 to 2.03; 1178 participants, 6 studies; P = 0.91; <a href="./references#CD007789-fig-0007" title="">Analysis 1.1</a>). There was no evidence of heterogeneity (Chi² = 2.42, df = 5 (P = 0.79); I² = 0%). and subgroup analysis comparing the results of trials with adequate dosing of both comparators with suboptimal NSAID dosing did not show subgroup differences (test for subgroup differences Chi² = 0.96, df = 1 (P = 0.33); I² = 0%). Pooled data (N = 818) from two studies found an little difference between groups in the number of participants with little or no pain in the first two hours (risk ratio (RR) 0.94, 95% CI 0.82 to 1.08, P = 0.40; <a href="./references#CD007789-fig-0008" title="">Analysis 1.2</a>), although there was some evidence of heterogeneity (Chi² = 2.06, df = 1 (P = 0.15); I² = 51%). </p> <p>There is high‐certainty evidence of no clinically important difference between NSAID and paracetamol in pain measured at one to three days (MD 1.50 mm, 95% CI ‐0.91 to 3.91; 1232 participants, 6 studies; P = 0.22, with some evidence of heterogeneity (Chi² = 10.08, df = 5 (P = 0.07); I² = 50%); <a href="./references#CD007789-fig-0009" title="">Analysis 1.3</a>). Subgroup analysis comparing the results of trials with suboptimal and adequate dosing did not show subgroup differences (test for subgroup differences: Chi² = 4.28, df = 2 (P = 0.12); I² = 53.2%). Sensitivity analysis excluding two studies, <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a> and <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>, at unclear risk of blinding did not substantially alter the result (MD ‐0.51 mm, 95% CI ‐3.58 to 2.56; P = 0.75). Pooled data (N = 894) from three studies found little difference between groups in the number of participants with little or no pain at day three (RR 1.10, 95% CI 0.96 to 1.27; P = 0.16; <a href="./references#CD007789-fig-0010" title="">Analysis 1.4</a>). </p> <p>At day four, <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a> (N = 204), which had suboptimal dosing of both comparators, found no clinically important difference between the groups (MD ‐0.68 mm, 95% CI ‐6.09 to 4.73; <a href="./references#CD007789-fig-0011" title="">Analysis 1.5</a>). This study was at high risk of bias for selective outcome reporting, as it only sufficiently reported the per‐protocol population to include in the analysis. <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a> reported that there was no difference between the groups in pain at day five, but did not provide data for us to include in the meta‐analysis. </p> <p>There is low‐certainty evidence of no clinically important difference between NSAID and paracetamol in pain measured at day seven or beyond (MD 1.55 mm, 95% CI ‐0.33 to 3.43; 467 participants, 4 studies; P = 0.11; <a href="./references#CD007789-fig-0012" title="">Analysis 1.6</a>). There is evidence of heterogeneity (Chi² = 8.11, df = 3 (P = 0.04); I² = 63%), and subgroup analysis comparing the results of trials with adequate dosing of both comparators with those with suboptimal dosing of one or more comparators showed evidence of subgroup differences (test for subgroup differences: Chi² = 7.50, df = 2 (P = 0.02); I² = 73.3%). The studies with adequate dosing of both comparators or suboptimal paracetamol dosing favoured paracetamol, while the study with suboptimal dosing of both comparators, <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a>, favoured NSAID. However, none of the observed differences in these subgroups or for individual studies were clinically important. </p> <p><a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a> (N = 76), which had adequate dosing of both comparators, found little difference between groups in the number of participants with little or no pain at day seven (RR 0.96, 95% CI 0.71 to 1.28; <a href="./references#CD007789-fig-0013" title="">Analysis 1.7</a>;). </p> </section> <section id="CD007789-sec-0083"> <h5 class="title">Swelling</h5> <p>Overall, there was low‐certainty evidence of little between‐groups difference in swelling. <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a> (N = 86) reported a statistically significant but clinically unimportant difference at day three in swelling, measured by volume, in favour of paracetamol (MD 4.30 mL, 95% CI 0.79 to 7.81; P = 0.02; <a href="./references#CD007789-fig-0014" title="">Analysis 1.8</a>). This study used a suboptimal dose of paracetamol, and was at unclear risk of bias for blinding. <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a> (N = 204), which used a subjective measure of swelling (100‐mm VAS) assessed by the investigator at day four, found no important difference between groups (MD ‐2.03 mm, 95% CI ‐7.71 to 3.65; P = 0.48; <a href="./references#CD007789-fig-0015" title="">Analysis 1.9</a>). This study used suboptimal dosing of both comparators, and was at high risk of bias for selective outcome reporting. Using the same measures at day seven or later, both of these studies found minimal difference between the two groups at day 9 and day 10 (<a href="./references#CD007789-fig-0016" title="">Analysis 1.10</a>). </p> <p>Another study, <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a> (N = 77), which used adequate dosing of both comparators, found little difference between groups in the numbers of participants with little or no swelling on day seven (22/41 versus 23/36; RR 0.84, 95% CI 0.58 to 1.22; <a href="./references#CD007789-fig-0017" title="">Analysis 1.11</a>). </p> <p>Two studies, both of which used suboptimal doses of paracetamol, reported means of small categorical scales. These studies reported no difference between the groups at day two (<a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>), or at day five (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>). <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a> also reported no difference at day 10, or at six weeks. </p> </section> <section id="CD007789-sec-0084"> <h5 class="title">Function</h5> <p>Two studies (N = 131) reported the number of participants with better function within the first seven days of treatment. <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>, with adequate dosing of both comparators, used a four‐point scale of self‐assessed disability. <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>, with suboptimal paracetamol dosing, reported the number of participants returning to sporting activity. As the pooled analysis of these two studies shows substantial heterogeneity (Chi² = 4.82, df = 1 (P = 0.03); I² = 79%), we present the results of each trial separately in <a href="./references#CD007789-fig-0018" title="">Analysis 1.12</a>. <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>, which is at high risk of bias for allocation concealment, found in favour of NSAID whereas <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a> found no difference between the groups (18/41 versus 17/35; RR 0.90, 95% CI 0.56 to 1.47; P = 0.68). </p> <p>The very low‐certainty evidence from three studies (N = 386) of minimal difference in the numbers of people returning to full activity by day seven or beyond means we are uncertain of these findings (RR 0.99, 95% CI 0.90 to 1.09; <a href="./references#CD007789-fig-0019" title="">Analysis 1.13</a>). There was no heterogeneity between the groups (Chi² = 0.88, df = 2 (P = 0.65); I² = 0%). </p> <p>Two studies reported the mean time to return to normal activity, with no conclusive difference between the groups in either study. <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a> (N = 100), used a suboptimal dose of paracetamol, and was at unclear risk of bias for blinding (MD ‐0.18, 95% CI ‐0.79 to 0.43; <a href="./references#CD007789-fig-0020" title="">Analysis 1.14</a>). <a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a> (N = 255), which used a suboptimal dose of both medications, reported a mean return to activity of 4.1 days in the NSAID group and 4.0 days in the paracetamol group. </p> <p><a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a> (N = 100) reported no important clinical difference between groups in the range of motion of the injured ankle joint at six weeks (MD 0.70 degrees, 95% CI ‐0.62 to 2.02; P = 0.3; <a href="./references#CD007789-fig-0021" title="">Analysis 1.15</a>). </p> <p>One study sought data on time to return to function but did not report this outcome (<a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>). </p> </section> <section id="CD007789-sec-0085"> <h5 class="title">Adverse effects</h5> <p>There is low‐certainty evidence of an increased risk of gastrointestinal adverse effects with NSAID compared with paracetamol (74/788 versus 54/716; RR 1.34, 95% CI 0.97 to 1.86; 1504 participants, 10 studies; <a href="./references#CD007789-fig-0022" title="">Analysis 1.16</a>). However, 95% CI include the possibility of no difference or a very small increased risk for paracetamol. There was no evidence of heterogeneity between studies (Chi² = 6.81, df = 8 (P = 0.56); I² = 0%). Subgroup analysis comparing the results of trials with adequate dosing of both medications with trials with suboptimal dosing of paracetamol, or NSAIDs, or both, also showed no evidence of subgroup differences (test for subgroup differences Chi² = 3.29, df = 3 (P = 0.35); I² = 8.8%). A sensitivity analysis excluding three studies (245 participants; <a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a>; <a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a>) at unclear risk of bias for blinding found no evidence of a difference between the two groups (RR 1.16, 95% CI 0.79 to 1.69; P = 0.44). </p> <p><a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a> (N = 365) gave all participants omeprazole to offset potential gastrointestinal adverse effects. This study reported approximately triple the rate of gastrointestinal adverse effects in all participants (23%) compared with other studies combined (8%). <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a> found fewer participants with gastrointestinal adverse effects in the NSAID group on day three (37/183 versus 47/182; RR 0.78, 95% CI 0.54 to 1.14; P = 0.25). Due to possible confounding from the addition of omeprazole, we did not include these data in the pooled analysis. </p> <p>There is low‐certainty evidence from nine studies (N = 1679) of little difference between groups for neurological adverse effects (64/876 verus 74/803; RR 0.85, 95% CI 0.62 to 1.17; P = 0.33; <a href="./references#CD007789-fig-0023" title="">Analysis 1.17</a>). There was no evidence of heterogeneity (Chi² = 1.70, df = 6 (P = 0.94); I² = 0%), and no evidence of subgroup differences based on dosing (test for subgroup differences (Chi² = 1.65, df = 3 (P = 0.65); I² = 0%). </p> <p>None of the studies reported any serious adverse events.</p> </section> <section id="CD007789-sec-0086"> <h5 class="title">Early re‐injury</h5> <p>No studies reported any re‐injury events.</p> </section> </section> <section id="CD007789-sec-0087"> <h4 class="title">2. NSAIDs versus opioids</h4> <p>Six studies (1212 participants) compared NSAIDs with opioids (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>). </p> <section id="CD007789-sec-0088"> <h5 class="title">Pain</h5> <p>Four studies (N = 1058) measured this outcome; two with adequate dosing (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>), one with suboptimal doses of NSAID (<a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>), and one with suboptimal doses of opioid (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>). </p> <p>There is moderate‐certainty evidence of no difference between groups for pain relief at 60 minutes on a 100‐mm VAS scale (MD ‐0.49 mm, 95% CI ‐3.05 to 2.07; 1058 participants, 4 studies; <a href="./references#CD007789-fig-0024" title="">Analysis 2.1</a>). There was little evidence of heterogeneity (Chi² = 4.57, df = 3 (P = 0.21); I² = 34%), and no evidence of a difference between subgroups (test for subgroup differences: Chi² = 1.44, df = 2 (P = 0.49), I² = 0%). In contrast, <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a> (134 participants) found a higher proportion of people in the NSAID group had little or no pain at one hour (very low‐certainty evidence; <a href="./references#CD007789-fig-0025" title="">Analysis 2.2</a>). </p> <p>Only <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> (N = 706), which used a suboptimal dose of the opioid, reported pain beyond the first 24 hours. Although favouring the NSAID, differences were clinically unimportant at both day four (MD ‐2.9 mm, 95% CI ‐6.06 to 0.26 mm; <a href="./references#CD007789-fig-0026" title="">Analysis 2.3</a>), and day seven (MD ‐6.50 mm, 95% CI ‐9.31 to ‐3.69 mm; <a href="./references#CD007789-fig-0027" title="">Analysis 2.4</a>). </p> <p><a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a> (N = 68), which presented pain data as the mean of a small categorical scale, measured daily for 14 days, and reported no difference between the groups on any day. (Data were not available to include in the analysis.) </p> </section> <section id="CD007789-sec-0089"> <h5 class="title">Swelling</h5> <p>Two studies recorded this outcome, but data were only available for analysis from <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> (N = 84). There is very low‐certainty evidence of little difference between the two groups in the number of participants with swelling at day 10 (RR 1.14, 95% CI 0.61 to 2.13; <a href="./references#CD007789-fig-0028" title="">Analysis 2.5</a>). <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a> (N = 68), reported swelling as the mean of a small categorical scale, measured daily for 14 days, and reported a small statistically significant difference (in the order of 5%) between the groups favouring NSAID at days two to six; however, the clinical importance of this difference is uncertain. </p> </section> <section id="CD007789-sec-0090"> <h5 class="title">Function</h5> <p>There is low‐certainty evidence from two studies (N = 705), one with adequate dosing (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>), and one with suboptimal doses of opioid (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>), of a greater return to function in the NSAID group (204/470 versus 78/235; RR 1.22, 95% CI 0.99 to 1.49; P = 0.06; <a href="./references#CD007789-fig-0029" title="">Analysis 2.6</a>), with no evidence of heterogeneity (Chi² = 0.91, df = 1 (P = 0.34); I² = 0%). The results were dominated by the data from <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> (N = 642), which, unlike <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>, was at low risk of detection bias. Likewise, a greater proportion of participants who took NSAIDs returned to function on or after day seven than of those who took opioids (366/484 versus 176/265; RR 1.13, 95% CI 1.03 to 1.25; P = 0.01; 2 studies, 749 participants; <a href="./references#CD007789-fig-0030" title="">Analysis 2.7</a>), with no evidence of heterogeneity (Chi² = 0.09, df = 1 (P = 0.76); I² = 0%); again, this result was dominated by the data from <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> (N = 686). </p> <p><a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>, which was at high risk of bias for incomplete outcome data, found that participants treated with an NSAID had a statistically significant, though small, difference in step length for the affected versus the unaffected limb, compared with those who took opioids (reported difference between limbs 5.0 cm, 95% CI 0.7 to 10.26 cm less). <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> also reported no difference in ankle range of motion between NSAID and opioid‐treated participants. </p> </section> <section id="CD007789-sec-0091"> <h5 class="title">Adverse effects</h5> <p>Five studies (N = 1151) measured adverse events, three with adequate dosing of both comparators (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>; <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>), one with suboptimal dosing of opioid (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>), and one with suboptimal dosing of NSAID (<a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>). </p> <p>There is moderate‐certainty evidence of fewer gastrointestinal adverse effects with NSAID compared with opioid (78/658 versus 101/493; RR 0.48, 95% CI 0.36 to 0.62; P &lt; 0.001; 1151 participants, 5 studies; <a href="./references#CD007789-fig-0031" title="">Analysis 2.8</a>). There was evidence of some heterogeneity (Chi² = 8.82, df = 4 (P = 0.07); I² = 55%), due to discordant results of one small study (<a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>). There was no evidence of subgroup differences, based on adequate dosing of the comparators (test for subgroup differences Chi² = 2.60, df = 2 (P = 0.27); I² = 23.1%); I² dropped to zero on the removal of <a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a>. </p> <p>There is moderate‐certainty evidence of fewer neurological adverse effects with NSAID compared with opioid (68/658 versus 100/493; RR 0.40, 95% CI 0.30 to 0.53; P &lt; 0.001; 1151 participants, 5 studies; <a href="./references#CD007789-fig-0032" title="">Analysis 2.9</a>), with no evidence of heterogeneity (Chi² = 1.27, df = 3 (P = 0.74); I² = 0%), and no evidence of subgroup differences (test for subgroup differences (Chi² = 0.87, df = 2 (P = 0.65); I² = 0%). </p> <p><a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> also reported other system adverse effects; however, the study reported these at the individual type of adverse event level rather than the participant level. <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> reported that 18% of participants taking non‐selective NSAIDs had some sort of adverse event compared with 20% of those taking opioids, but did not report these events in sufficient detail to allow inclusion in the analyses. </p> <p>None of the studies reported serious adverse events, although <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> treated one child successfully for an accidental overdose of opioid (this participant was withdrawn from the study). </p> </section> <section id="CD007789-sec-0092"> <h5 class="title">Early re‐injury</h5> <p>No studies reported on re‐injury.</p> </section> </section> <section id="CD007789-sec-0093"> <h4 class="title">3. NSAID versus combination analgesics (paracetamol and opioid)</h4> <p>Four studies (240 participants) compared NSAIDs with combined analgesics (paracetamol plus an opioid; <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>). </p> <p>One study used suboptimal doses of both comparators (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>). We anticipate that the other three studies used the standard doses as marketed, although the dose of paracetamol was suboptimal in all proprietary preparations combining paracetamol with opioid (<a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>). </p> <p>The evidence for all reported outcomes was very low‐certainty meaning that we have very little confidence in the effect estimates. This primarily reflects the low numbers of participants available and thus very serious imprecision. </p> <section id="CD007789-sec-0094"> <h5 class="title">Pain</h5> <p><a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>, the only study (N = 51) reporting on pain in the first 24 hours, found just one person, who was in the NSAID group, who experienced little or no pain (<a href="./references#CD007789-fig-0033" title="">Analysis 3.1</a>). </p> <p>Pooled data (N = 149) from two studies showed little difference between the groups in the numbers of participants with little or no pain at days one to three (12/74 versus 8/74; RR 1.49, 95% CI 0.65 to 3.40; P = 0.34; <a href="./references#CD007789-fig-0034" title="">Analysis 3.2</a>). There was no evidence of heterogeneity (Chi² = 0.05, df = 1 (P = 0.82); I² = 0%). <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> (N = 98), which was at high risk for blinding of treatment providers, found little difference between groups in the number of participants with little or no pain at day five (RR 1.33, 95% CI 0.78 to 2.29; P = 0.3; <a href="./references#CD007789-fig-0035" title="">Analysis 3.3</a>). </p> <p>Pooled data (N = 138) from two studies showed little difference between the groups in the proportion of participants with little or no pain at day seven (49/68 versus 47/70; RR 1.05, 95% CI 0.88 to 1.25; with no evidence of heterogeneity (Chi² = 0.69, df = 1 (P = 0.41); I² = 0%; <a href="./references#CD007789-fig-0036" title="">Analysis 3.4</a>). </p> <p>We excluded data from three studies that reported means of small categorical scales from the meta‐analysis for pain (<a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a>; <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>). <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a> (N = 50) reported no difference between the groups at all time points up to day seven. At day seven, <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> (N = 98) found a statistically significant difference of 0.5 on a 4‐point scale favouring NSAID (this is of uncertain clinical significance), and <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a> (N = 82) found no difference. </p> <p>We also excluded data from one study that used a numeric rating scale (NRS), as more than 30% of the population had inflammatory conditions, and data for participants with injuries (N = 134) were insufficiently reported to enable us to include them in the meta‐analysis (<a href="./references#CD007789-bbs2-0022" title="BuccellettiF , MarsilianiD , ZuccalaG , IacominiP , ProiettiL , PolaE , et al. Paracetamol-codeine compared to ketorolac for pain control in the emergency department. European Review for Medical and Pharmacological Sciences2014;18(20):3139-43. ">Buccelletti 2014</a>). The authors reported there was no difference between the groups at 30 minutes (P = 0.77), and 120 minutes (P = 0.48). </p> </section> <section id="CD007789-sec-0095"> <h5 class="title">Swelling</h5> <p>Three studies measured swelling, but all used the means of small categorical scales, therefore, we just reported the results from the publications. Two reported that at days three, five, and seven, there were no significant differences between the groups (<a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a>, N = 82; <a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a>, N = 50). <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> (N = 98) reported that no difference between groups on day seven. </p> </section> <section id="CD007789-sec-0096"> <h5 class="title">Function</h5> <p><a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> (N = 89) found an inconclusive difference between the groups in the number of participants 'cured' by day seven (RR 1.28, 95% CI 0.90 to 1.81; P = 0.17; <a href="./references#CD007789-fig-0037" title="">Analysis 3.5</a>). <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> (N = 89) and <a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a> (N = 40) reported function as a mean limitation of movement on a small categorical scale on day seven; both reported no significant difference between groups. </p> </section> <section id="CD007789-sec-0097"> <h5 class="title">Adverse effects</h5> <p>These were reported by all four trials but we did not include the results from <a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> (N = 98) in the analyses as they reported at the event level rather than the participant level. </p> <p>There was little evidence of a difference in the numbers of participants who developed gastrointestinal adverse events reported in three other trials (0/70 versus 4/70; RR 0.21, 95% CI 0.03 to 1.74; P = 0.15; 141 participants, 3 studies; <a href="./references#CD007789-fig-0038" title="">Analysis 3.6</a>). </p> <p>Pooled data (N = 141) from the same three studies also found little difference between groups in neurological adverse effects (1/70 versus 3/71; RR 0.52, 95% CI 0.09 to 2.84; P = 0.45; <a href="./references#CD007789-fig-0039" title="">Analysis 3.7</a>). </p> <p><a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a> (N = 50) reported one participant with a rash in the NSAID group, and none in the paracetamol plus opioid group. </p> <p>None of the studies reported any serious adverse events.</p> </section> <section id="CD007789-sec-0098"> <h5 class="title">Early re‐injury</h5> <p>No studies reported any re‐injury events.</p> </section> </section> <section id="CD007789-sec-0099"> <h4 class="title">Subgroup analysis of the three different comparators</h4> <p>We undertook exploratory subgroup analyses to examine differences between the results of the three comparisons (NSAIDs versus paracetamol, versus opioids, and versus combined paracetamol and opioid analgesics). Sufficient data were available for pain in the first one to two hours of treatment, and gastrointestinal and neurological adverse effects. </p> <section id="CD007789-sec-0100"> <h5 class="title">Pain</h5> <p>Exploratory subgroup analysis, involving nine trials, of pain scores in the first one to two hours of treatment, measured on a 100‐mm VAS, showed no evidence of a difference between two subgroups (NSAID versus paracetamol; NSAID versus opioid): test for subgroup differences: Chi² = 0.05, df = 1 (P = 0.83); I² = 0% (<a href="./references#CD007789-fig-0040" title="">Analysis 4.1</a>; <a href="#CD007789-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD007789-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.1 Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst)." data-id="CD007789-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.1 Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst). </p> </div> </div> </div> </section> <section id="CD007789-sec-0101"> <h5 class="title">Adverse effects</h5> <p>Exploratory subgroup analysis, involving 17 studies, of gastrointestinal adverse effects showed a difference between the three groups: test for subgroup differences: Chi² = 24.69, df = 2 (P &lt; 0.00001), I² = 91.9% (<a href="./references#CD007789-fig-0041" title="">Analysis 4.2</a>; <a href="#CD007789-fig-0005">Figure 5</a>). This is consistent with the expected differences in gastrointestinal adverse effects profiles of paracetamol and opioids relative to NSAIDs. </p> <div class="figure" id="CD007789-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.2 Gastrointestinal adverse events." data-id="CD007789-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.2 Gastrointestinal adverse events. </p> </div> </div> </div> <p>Exploratory subgroup analysis, involving 16 studies, of neurological adverse effects showed a difference between the three groups: test for subgroup differences: Chi² = 12.73, df = 2 (P = 0.002), I² = 84.3% (<a href="./references#CD007789-fig-0042" title="">Analysis 4.3</a>; <a href="#CD007789-fig-0006">Figure 6</a>). This is consistent with the expected differences in neurological adverse effects profiles of paracetamol and opioids relative to NSAIDs. </p> <div class="figure" id="CD007789-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.3 Neurological adverse events." data-id="CD007789-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.3 Neurological adverse events. </p> </div> </div> </div> <p>Notably, none of the studies reported any serious adverse effects, although one participant was withdrawn from <a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> for an accidental overdose of opioid. </p> </section> </section> <section id="CD007789-sec-0102"> <h4 class="title">Subgroup analyses that were planned but not done</h4> <section id="CD007789-sec-0103"> <h5 class="title">By age</h5> <p>There are insufficient studies and data to undertake formal subgroup analysis by age. The three studies comparing NSAIDs and paracetamol that exclusively enrolled participants younger than 18 years of age tested two comparisons: NSAID versus paracetamol (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>) and NSAID versus opioid (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>; <a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a>). The youngest participant was six years old. Five other studies may have included participants who were under 18 years, but we were unable to disaggregate the data specific to paediatric participants (<a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>; <a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a>; <a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a>; <a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a>; <a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a>). No other studies enrolled paediatric participants. </p> <p>Although some studies may have included participants over 65 years old, for all but one study, we were unable to disaggregate the data specific to them. <a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>, which did not specify an upper age limit, reported data separately for 28 of 365 included participants who were 60 years and older; they found no subgroup difference between the younger and older participants for pain. </p> <p>The average age of participants enrolled in studies across all comparisons was between 20 and 35 years, and thus the results may not be generalised to older adults. </p> </section> <section id="CD007789-sec-0104"> <h5 class="title">COX‐2 selective NSAIDs versus non‐selective NSAIDs</h5> <p>There were insufficient studies using different types of NSAID (COX‐2 selective and non‐selective) to undertake subgroup analysis. </p> </section> </section> <section id="CD007789-sec-0105"> <h4 class="title">NSAIDs versus complementary and alternative medicines</h4> <p>We identified no studies that explored this comparison, although one study awaiting classification may meet criteria for inclusion when completed <a href="./references#CD007789-bbs2-0072" title="TCTR20160126001. Efficacy and safety of extracted Prasaplai for relieving acute muscle strain. apps.who.int/trialsearch/Trial2.aspx?TrialID=TCTR20160126001 (first received 25 January 2016). ">TCTR20160126001</a> </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007789-sec-0106" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007789-sec-0106"></div> <section id="CD007789-sec-0107"> <h3 class="title" id="CD007789-sec-0107">Summary of main results</h3> <p>We included 20 studies; 11 studies compared non‐steroidal anti‐inflammatory drugs (NSAIDs) with paracetamol, six studies compared NSAIDs with opioids, and four compared NSAIDs with combined analgesics comprising paracetamol and an opioid. One study included all three comparators (<a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a>). Although some evidence was high certainty or moderate certainty, the majority of the evidence was either low certainty, meaning that our confidence in the effect estimate is limited and the true effect may be substantially different from the estimate of the effect, or very low certainty, meaning that we have very little confidence in the effect estimate, and the true effect is likely to be substantially different from the estimate of effect. </p> <p>We found no studies comparing NSAID versus oral complementary and alternative medicines.</p> <section id="CD007789-sec-0108"> <h4 class="title">NSAIDs versus paracetamol</h4> <p><a href="https://archie.cochrane.org/sections/documents/view?version=z2006251001098302685336155402671&amp;format=JATS#SOF-01" target="_blank">Summary of findings table 1</a> summarises the findings for the outcomes for this comparison. The evidence for outcomes ranged from moderate certainty to very low certainty.<br/>There is high‐certainty evidence of no clinically important differences between the two groups (NSAID versus paracetamol) in pain, measured on a visual analogue scale, at one to two hours (1178 participants, 6 studies) and at one to three days (1232 participants, 6 studies). There was low‐certainty evidence of no clinically important difference between the two groups at day seven or later (467 participants, 4 studies).<br/>There is low‐certainty evidence of little difference between the two groups in the numbers of participants with no or little swelling at day seven or later (77 participants, 1 study; consistent data also from two studies with 290 participants). There is very low‐certainty evidence of no difference between groups in return to function at day seven or later (386 participants, 3 studies).<br/>Low certainty evidence (1504 participants, 10 studies) indicates that NSAID may increase the risk of gastrointestinal adverse events; however, the 95% CI includes the possibility of a very slight increase with paracetamol. Based on an assumed risk of gastrointestinal adverse events of 75 per 1000 participants in the paracetamol group, 26 more participants per 1000 had a gastrointestinal adverse event in the NSAID group (95% CI 2 fewer to 65 more). There is low‐certainty evidence that there may be little difference between NSAID and paracetamol in the risk of neurological adverse events (1679 participants, 9 studies). Based on an assumed risk of neurological adverse events on 92 per 1000 participants in the paracetamol group, 14 fewer participants per 1000 had a neurological adverse event in the NSAID group (95% CI 35 fewer to 16 more). None of the studies reported re‐injury. </p> </section> <section id="CD007789-sec-0109"> <h4 class="title">NSAIDs versus opioids</h4> <p><a href="./full#CD007789-tbl-0002">summary of findings Table 2</a> summarises the findings for the outcomes for this comparison. The evidence for outcomes ranged from moderate certainty to very low certainty. </p> <p>There was moderate‐certainty evidence of no clinically important difference between NSAIDs and opioids for pain, measured on a visual analogue scale, at one hour (1058 participants, 4 studies). There was low‐certainty evidence of no clinically important differences between the groups at day four (706 participants, 1 study) or at day seven. The confidence intervals for all three time points were smaller than the minimum clinically detectable difference in pain score (13 mm on a 100‐mm VAS). </p> <p>There was very low‐certainty evidence of little clinically important difference between the groups in swelling (1 study, 84 participants). There was low‐certainty evidence that participants in the NSAID group were more likely to return to function in 7 to 10 days (2 studies, 749 participants). </p> <p>There was moderate‐certainty evidence from five studies (1143 participants) that those who took NSAIDs were less likely to develop either gastrointestinal or neurological adverse events compared with opioid. Based on an assumed risk of 205 per 100 participants in the opioid group, 107 fewer participants per 1000 had an gastrointestinal adverse event in the NSAID group (95% CI 78 to 131 fewer). Based on an assumed risk of 203 per 1000 participants in the opioid group, 122 fewer participants per 1000 had a neurological adverse event in the NSAID group (95% CI 95 to 142 fewer). None of the studies reported re‐injury. </p> </section> <section id="CD007789-sec-0110"> <h4 class="title">NSAIDs versus combination analgesics (paracetamol and opioid)</h4> <p><a href="./full#CD007789-tbl-0003">summary of findings Table 3</a> summarises the findings for the outcomes for this comparison, for which very limited data were available. The evidence for outcomes was very low certainty. </p> <p>There is very low‐certainty evidence of little difference between the two groups in the numbers reporting little or no pain on day one (51 participants, 1 study), days one to three (149 participants, 2 studies), and at day seven or later (138 participants, 2 studies). The confidence intervals were wide at each time point and crossed the line of no effect, and thus included the potential for a better outcome for either intervention.<br/>No usable data were available from the three studies (230 participants) reporting on swelling; very low‐certainty evidence from these did not indicate a clinically important difference between groups at day seven. There was very low‐certainty evidence of little difference between groups for those who reported a 'cure' at day seven (1 study, 89 participants).<br/>There is very low‐certainty evidence (141 participants, 3 studies) relating to gastrointestinal adverse events, of which all four cases occurred in the combined paracetamol and opioid group; and for neurological adverse events, where three of the four cases occurred in the combined group. The wide confidence intervals of both pooled analyses also include the potential for fewer adverse events for the paracetamol and opioid combination and illustrate the uncertainty surrounding these findings. None of the studies reported re‐injury. </p> </section> </section> <section id="CD007789-sec-0111"> <h3 class="title" id="CD007789-sec-0111">Overall completeness and applicability of evidence</h3> <section id="CD007789-sec-0112"> <h4 class="title">NSAIDs versus paracetamol</h4> <p>The results for this comparison are from 11 small to large size studies, with data available for pooling from a maximum of 1679 participants (9 studies); these data were for neurological adverse events. Participants were children (mean age of 12 years) in two studies, and mainly young adults in the other nine studies. The participants were predominantly from North America, Europe, and Asia. Four studies involved people with ankle sprains only, while the other seven studies had mixed populations of various soft tissue injuries. Both sexes were well represented, although there was a male predominance of approximately 60%. Generalisation to other populations, including elderly populations, may be limited. The results are more limited for the outcome of return to function, because few studies reported data sufficiently to enable us to include them in all analyses. Although there was suboptimal paracetamol dosing in three studies, and suboptimal dosing of NSAIDs in three studies, this reflected local practice, and did not appear to affect the results. Thus, the evidence is likely to be applicable to current practice. </p> </section> <section id="CD007789-sec-0113"> <h4 class="title">NSAIDs versus opioids</h4> <p>The results for this comparison are from three small, two moderate sized, and one large study. Most studies included various soft tissue injuries, but the largest trial, accounting for over half of the participants, included predominantly young, white adults with ankle sprains. Data available for pooling were from a maximum of 1151 participants (5 studies); these data were for gastrointestinal and neurological adverse events. Participants were children in one small and one moderate sized trial, and adults in the other four. Both sexes were well represented, although there was a male predominance of approximately 60%. Generalisation to other populations, including the elderly, may be limited. The particular COX‐2 selective NSAID (valdecoxib) used in the largest trial, was subsequently withdrawn from the market due to fears about cardiovascular toxicity; this limits the generalisability of the results for this comparison to some extent. </p> </section> <section id="CD007789-sec-0114"> <h4 class="title">NSAIDs versus combination analgesics (paracetamol and opioid)</h4> <p>The results for this comparison came from four small studies, with data available for pooling from a maximum of 149 participants (2 studies); these data were for pain at days one to three. One study included ankle sprains; one included ankle and wrist injuries; and there was a mixture of injuries in the remaining two studies. The studies exclusively enrolled young adults, in a variety of acute care settings; they did not report ethnicity. There was also a strong male predominance in these studies (more than 70%). Generalisation of these results to other populations may not be appropriate. These studies used suboptimal paracetamol doses because of the proprietary analgesic formulations, which may not be relevant to current practice, as these dextropropoxyphene combination analgesic agents are no longer in general use. </p> </section> </section> <section id="CD007789-sec-0115"> <h3 class="title" id="CD007789-sec-0115">Quality of the evidence</h3> <p>In our assessment of the certainty of the evidence, we downgraded for one of three reasons: study limitations, indirectness, and imprecision. </p> <section id="CD007789-sec-0116"> <h4 class="title">NSAIDs versus paracetamol</h4> <p>The reasons for our assessment of the certainty of evidence for each outcome displayed in <a href="./full#CD007789-tbl-0001">summary of findings Table 1</a> are presented in the footnotes. We assessed the evidence for pain at one or two hours and for pain at days one to three as high certainty. We downgraded the evidence for pain at day seven or later by two levels, to low certainty, because of study limitations and indirectness of the data. </p> <p>We downgraded the evidence for swelling at day seven or later by two levels to low certainty, because of study limitations and imprecision. Although binary data for this outcome were from one study only, volume data available from two other studies provided consistent evidence. We downgraded the evidence for return to function at day seven or later by three levels to very low certainty, reflecting serious study limitations and imprecision. Finally, we downgraded the evidence for gastrointestinal and neurological adverse events by one level to moderate‐certainty because of imprecision. </p> </section> <section id="CD007789-sec-0117"> <h4 class="title">NSAIDs versus opioids</h4> <p>The reasons for our assessment of the certainty of the evidence for each outcome displayed in <a href="./full#CD007789-tbl-0002">summary of findings Table 2</a> are presented in the footnotes. Half or more of the evidence for this comparison were from one large (706 participants) study that was at low risk of bias for all domains except for selective reporting of adverse events. However, because this study used a COX‐2 selective NSAID, which has been withdrawn from the market (Valdecoxib), and also used a suboptimal dosing of the opioid, we downgraded evidence for indirectness for outcomes it contributed data to. Thus, we downgraded the evidence for pain at less than 24 hours by one level to moderate quality because of indirectness. We downgraded pain at days four to six, and pain at day seven or later by two levels for indirectness to low certainty. We downgraded the evidence for swelling at day seven or later by three levels to very low certainty; this reflected downgrading for serious study limitations and imprecision. We downgraded the evidence for return to function at day seven or later by two levels to low certainty for serious indirectness. We downgraded the evidence for gastrointestinal and neurological adverse effects by one level for indirectness. </p> </section> <section id="CD007789-sec-0118"> <h4 class="title">NSAIDs versus combination analgesics (paracetamol and opioid)</h4> <p>The reasons for our assessment of the certainty of the evidence for each outcome displayed in <a href="./full#CD007789-tbl-0003">summary of findings Table 3</a> are presented in the footnotes. Two of the four trials for this comparison were at high risk of bias; and the other two were at unclear risk of several biases including selection bias. Hence, we downgraded the evidence by either one or two levels for study limitations. Another reason for downgrading was imprecision, especially where there were very few events. Another reason for downgrading was indirectness, which for swelling, reflected the inadequacy of outcome measurement. Another source of indirectness, which would have also counted against all four studies if the evidence from these had not already been downgraded, was that the dextropropoxyphene combination analgesic agents used by these now relatively dated studies, are no longer in general use. We downgraded the evidence for all outcomes by a minimum of three levels, to very low certainty. </p> </section> </section> <section id="CD007789-sec-0119"> <h3 class="title" id="CD007789-sec-0119">Potential biases in the review process</h3> <p>Although the search strategy was sensitive, it is still possible that we missed potentially relevant studies. To minimise bias in the review process, two review authors independently undertook study selection, data extraction, and assessment of risk of bias, using a standardised data extraction form, and resolving any discrepancies by consensus with a third author. Decisions to pool or not pool results, based on similarities or differences in subgroups, may have affected the results of the study. We preplanned subgroup analyses based on optimal and suboptimal dosing of comparator analgesics, and combined data when it was appropriate to do so, based on the test for subgroup differences. </p> <p>We included some studies with participants who did not have soft tissue injuries for which separate data were available. We think this is unlikely to be an important source of bias. All studies included a population that had 70% or more with soft tissue injuries; and effective randomisation should mean that the proportion of participants with other conditions, such as minor fractures, should be balanced among the treatment groups. From a clinical perspective in the acute setting, at the time of giving analgesia, it may not be known whether the injury is one of soft tissue or bone, so we believe this is a pragmatic, clinically relevant approach to dealing with this issue. </p> <p>In <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a>, which was a study run by a pharmaceutical company, the number of adverse events reported in the published article was substantially lower than that contained in unpublished trial data (356 versus 416 adverse events). As <a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> reported only adverse effects with at least 2% incidence, this could have resulted in an underestimation of the incidence of rare but potentially important adverse events. Four studies reported combined gastrointestinal and neurological adverse events at the event level rather than the participant level (<a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a>; <a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a>; <a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a>; <a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a>). For these studies, we included participant‐level data for the most common gastrointestinal or neurological adverse event. This may also have led to an underestimation of adverse events in this review. </p> </section> <section id="CD007789-sec-0120"> <h3 class="title" id="CD007789-sec-0120">Agreements and disagreements with other studies or reviews</h3> <p>A recent systematic review also reported no difference in analgesic efficacy between NSAIDs and paracetamol, although most of the analysis was narrative, with meta‐analysis restricted to four trials, and the outcome of pain was measured at rest (<a href="./references#CD007789-bbs2-0179" title="RidderikhofML , SaanenJ , GoddijnH , Van DierenS , Van Etten-JamaludinF , LirkP , et al. Paracetamol versus other analgesia in adult patients with minor musculoskeletal injuries: asystematic review. Emergency Medicine Journal2019;36(8):493-500.">Ridderikhof 2019</a>). There is also systematic review evidence that there is no difference in analgesic efficacy between COX‐2 selective and non‐selective NSAIDs when used for acute soft tissue injuries; in this setting, COX‐2 selective NSAIDs had fewer gastrointestinal adverse effects than non‐selective NSAIDs, although the quality of evidence was low (<a href="./references#CD007789-bbs2-0137" title="JonesP , LamdinR . Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis. Clinical Drug Investigation2010;30(7):419-37. [PMID: 20527999]">Jones 2010</a>). Our review showed that NSAIDs have more gastrointestinal adverse effects than paracetamol. However, the certainty of evidence was low. Of note, is that this effect was not found in (<a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a>), where all participants also received omeprazole, a proton pump inhibitor. Our review also showed that compared with opioid there were fewer gastrointestinal or neurological adverse effects when NSAID was used. This is consistent with other studies where opioid was used in the setting of acute soft tissue injury (<a href="./references#CD007789-bbs2-0116" title="GongJ , ColliganM , KirkpatrickC , JonesP . Oral paracetamol versus combination oral analgesics for acute musculoskeletal injuries. Annals of Emergency Medicine2019;74(4):521-9.">Gong 2019</a>; <a href="./references#CD007789-bbs2-0037" title="GraudinsA , MeekR , ParkinsonJ , Egerton-WarburtonD , MeyerA . A randomised controlled trial of paracetamol and ibuprofen with or without codeine or oxycodone as initial analgesia for adults with moderate pain from limb injury. Emergency Medicine Australasia2016;28(6):666-72. ">Graudins 2016</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007789-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for update" data-id="CD007789-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram for update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD007789-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies" data-id="CD007789-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.1 Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst)." data-id="CD007789-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.1 Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.2 Gastrointestinal adverse events." data-id="CD007789-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.2 Gastrointestinal adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.3 Neurological adverse events." data-id="CD007789-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 4 NSAID versus other oral analgesics, outcome: 4.3 Neurological adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 1: Pain &lt; 24 hours (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 1: Pain &lt; 24 hours (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 2: Little or no pain &lt; 24 hours" data-id="CD007789-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 2: Little or no pain &lt; 24 hours</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 3: Pain on days 1 to 3 (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 3: Pain on days 1 to 3 (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 4: Little or no pain on days 1 to 3" data-id="CD007789-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 4: Little or no pain on days 1 to 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 5: Pain on days 4 to 6 (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 5: Pain on days 4 to 6 (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 6: Pain on day 7 or later (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 6: Pain on day 7 or later (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 7: Little or no pain on day 7 or later" data-id="CD007789-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 7: Little or no pain on day 7 or later </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 8: Swelling on days 0 to 3" data-id="CD007789-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 8: Swelling on days 0 to 3</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 9: Swelling on days 4 to 6 (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 9: Swelling on days 4 to 6 (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 10: Swelling on day 7 or later" data-id="CD007789-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 10: Swelling on day 7 or later</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 11: Little or no swelling on day 7 or later" data-id="CD007789-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 11: Little or no swelling on day 7 or later </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 12: Return to function within 7 days" data-id="CD007789-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 12: Return to function within 7 days</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 13: Return to function in 7 days or later" data-id="CD007789-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 13: Return to function in 7 days or later </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 14: Time to return to full activity (days)" data-id="CD007789-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 14: Time to return to full activity (days) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 15: Range of motion (degrees)" data-id="CD007789-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 15: Range of motion (degrees)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 16: Gastrointestinal adverse events" data-id="CD007789-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 16: Gastrointestinal adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: NSAIDs versus paracetamol, Outcome 17: Neurological adverse events" data-id="CD007789-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: NSAIDs versus paracetamol, Outcome 17: Neurological adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 1: Pain &lt; 24 hours (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 1: Pain &lt; 24 hours (VAS: 0 to 100 mm: worst)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 2: Little or no pain &lt; 24 hours" data-id="CD007789-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 2: Little or no pain &lt; 24 hours</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 3: Pain on days 4 to 6 (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 3: Pain on days 4 to 6 (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 4: Pain on day 7 or later (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 4: Pain on day 7 or later (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 5: Swelling on day 7 or later" data-id="CD007789-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 5: Swelling on day 7 or later</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 6: Return to function within 7 days" data-id="CD007789-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 6: Return to function within 7 days</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 7: Return to function in 7 days or later" data-id="CD007789-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 7: Return to function in 7 days or later</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 8: Gastrointestinal adverse events" data-id="CD007789-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 8: Gastrointestinal adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: NSAID versus opioid, Outcome 9: Neurological adverse events" data-id="CD007789-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: NSAID versus opioid, Outcome 9: Neurological adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 1: Little or no pain &lt; 24 hours" data-id="CD007789-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 1: Little or no pain &lt; 24 hours </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 2: Little or no pain on days 1 to 3" data-id="CD007789-fig-0034" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 2: Little or no pain on days 1 to 3 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 3: Little or no pain on days 4 to 6" data-id="CD007789-fig-0035" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 3: Little or no pain on days 4 to 6 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 4: Little or no pain on day 7 or later" data-id="CD007789-fig-0036" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 4: Little or no pain on day 7 or later </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 5: Return to function in 7 days or later" data-id="CD007789-fig-0037" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 5: Return to function in 7 days or later </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 6: Gastrointestinal adverse events" data-id="CD007789-fig-0038" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 6: Gastrointestinal adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 7: Neurological adverse events" data-id="CD007789-fig-0039" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: NSAID versus combination analgesic (paracetamol + opioid), Outcome 7: Neurological adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: NSAID versus other oral analgesics, Outcome 1: Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst)" data-id="CD007789-fig-0040" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: NSAID versus other oral analgesics, Outcome 1: Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: NSAID versus other oral analgesics, Outcome 2: Gastrointestinal adverse events" data-id="CD007789-fig-0041" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: NSAID versus other oral analgesics, Outcome 2: Gastrointestinal adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007789-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/urn:x-wiley:14651858:media:CD007789:CD007789-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: NSAID versus other oral analgesics, Outcome 3: Neurological adverse events" data-id="CD007789-fig-0042" src="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_t/tCD007789-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: NSAID versus other oral analgesics, Outcome 3: Neurological adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/media/CDSR/CD007789/image_n/nCD007789-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007789-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">NSAID compared with paracetamol for acute soft tissue injury</span></div> <tbody> <tr class="separated"> <th align="left" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>NSAID compared with paracetamol for acute soft tissue injury</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute soft tissue injury, such as ankle sprain<br/><b>Setting:</b> various outpatient locations (e.g. emergency department, student health centre)<br/><b>Intervention:</b> NSAID<br/><b>Comparison:</b> paracetamol </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with paracetamol</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NSAIDs</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 1 to 2 hours</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across paracetamol groups from 43 to 55 mm; and ‐12 to ‐19 mm mean reduction from baseline </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the NSAID groups was 0.12 mm lower<br/>(2.27 lower to 2.03 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1178<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies included mixed STI populations.</p> <p>The confidence interval did not reach the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at days 1 to 3 (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 2 to 3 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across paracetamol groups from 11.9 to 36.7 mm; and ‐12.7 to ‐18.3 mm mean reduction from baseline </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the NSAID groups was 1.5 mm higher<br/>(0.91 lower to 3.91 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1232<br/>(6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies included ankle sprains and four included mixed STI populations.</p> <p>The confidence interval did not reach the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain on day 7 or later (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 7 to 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across control groups from 5.0 to 6.3 mm; with ‐54.4 mm mean reduction from baseline </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the NSAID groups was 1.55 mm higher<br/>(0.33 lower to 3.43 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>467<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All four studies included ankle sprains; one included only children.</p> <p>The confidence interval did not reach the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no swelling on day 7 or later</b> </p> <p><i>Follow‐up: 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/>(0.58 to 1.22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The study included children with ankle sprains only.</p> <p>This lack of difference was also found by two more studies (290 participants) involving ankle sprains that presented continuous (volume and VAS) data </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>639 per 1000<sup>c</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>537 per 1000<br/>(371 to 779) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Return to function on day 7 or later</b><sup>e</sup> </p> <p><i>Follow‐up: 9 to 14 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.99<br/>(0.90 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>386<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Two studies included ankle sprains; one included children only, and one included a mixed STI population. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>820 per 1000<sup>f</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>812 per 1000<br/>(738 to 894) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Gastrointestinal adverse events</b> </p> <p><i>Follow‐up: 1 hour to 30 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.34<br/>(0.97 to 1.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1504<br/>(10 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>i</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies included ankle sprains, one included children only, and six included mixed STI populations. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>75 per 1000<sup>h</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>101 per 1000<br/>(73 to 140) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurological adverse events</b><br/><i>Follow‐up: 1 hour to 30 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/>(0.62 to 1.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1679<br/>(9 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>j</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies included ankle sprains, one included children only, and five included mixed STI populations. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92 per 1000<sup>h</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/>(57 to 108) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Early re‐injury</b> (within 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study reported this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MCID:</b> minimal clinically important difference; <b>RR:</b> risk ratio; <b>STI:</b> soft tissue injury </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty.</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty.</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty.</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty.</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> One study (100 participants) at unclear risk of bias across all domains slightly favoured paracetamol, while five others at low risk of bias did not. The evidence was not downgraded for risk of bias or inconsistency as including this study did not impact the finding of no statistically significant or clinically important difference<br/><sup>b</sup> We downgraded the evidence by one level for study limitations (three studies were at unclear risk of several biases, including selection bias), and one level for indirectness reflecting suboptimal dosing of paracetamol in two studies (although these favoured paracetamol), and of both comparators in one study. Although there was inconsistency, reflecting statistically significant heterogeneity (P = 0.04; I² = 63%) of the pooled results, we did not consider this a reason to further downgrade the evidence, given the lack of clinical significance of the individual results of these studies<br/><sup>c</sup> Assumed risk = control group risk in the study reporting this outcome<br/><sup>d</sup> We downgraded the evidence by one level for study limitations (the sole study reporting this outcome was at unclear risk of bias relating to incomplete data for this outcome), and one level for imprecision (wide confidence intervals)<br/><sup>e</sup> Function assessed differently in each study: numbers with no disability at day 14; numbers resuming sporting activity at day 10; and numbers who had resumed normal activity at day 9<br/><sup>f</sup> Assumed risk = median control group risk in the studies reporting this outcome<br/><sup>g</sup> We downgraded the evidence by two levels for study limitations (one study was at high risk of selection bias and one at high risk of reporting bias), and one level for imprecision. Of note is the suboptimal dosing of paracetamol in one study, and of both comparators in another study.<br/><sup>h</sup> Assumed risk = average risk for those in the paracetamol groups<br/><sup>i</sup> We downgraded the evidence two levels for imprecision, as the lower confidence level just passed the point of no difference and the upper confidence level indicates an important difference<br/><sup>j</sup> We downgraded the evidence two levels for imprecision, as the confidence interval was wide and included both benefit and harm </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">NSAID compared with paracetamol for acute soft tissue injury</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007789-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAID compared with opioid for acute soft tissue injury</span></div> <tbody> <tr class="separated"> <th align="left" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>NSAID compared with opioid for acute soft tissue injury</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> acute soft tissue injury<br/><b>Setting:</b> various outpatient locations (e.g. emergency department, sports club)<br/><b>Intervention:</b> NSAID<br/><b>Comparison:</b> opioid </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with opioid</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with NSAID</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 1 hour</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score ranged across opioid groups from 13 to 27.7 mm</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the NSAID group was 0.49 mm lower<br/>(3.05 lower to 2.07 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1058<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Three studies included a mixed STI population, one in children; the other study involved ankle sprains. </p> <p>The confidence interval did not include the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at days 4 to 6 (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 4 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the opioid group was 31.8 mm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the NSAID group was<br/>2.9 mm lower (6.06 lower to 0.26 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There were no data for the earlier interim period (up to 3 days).</p> <p>The study included ankle sprains.</p> <p>The confidence interval did not include the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain on day 7 or later (VAS: 0 to 100 mm: worst)</b> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain score in the opioid group was 15.1 mm</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean pain in the NSAID group was 6.5 mm lower<br/>(9.31 lower to 3.69 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study included ankle sprains.</p> <p>The confidence interval did not include the MCID (13 mm).</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no swelling on day 7 or later</b> </p> <p><i>Follow‐up: 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.14<br/>(0.61 to 2.13) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>84<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>The study included ankle sprains</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000<sup>c</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>342 per 1000<br/>(183 to 639) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Return to function on day 7 or later</b> </p> <p><i>(numbers returning to full function or returning to training)</i> </p> <p><i>Follow‐up: 7 to 10 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/>(1.03 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>749<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study included ankle sprains, and one a mixed STI population.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>664 per 1000<sup>e</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>750 per 1000<br/>(684 to 830) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Gastrointestinal adverse events</b> </p> <p><i>Follow‐up: 2 hours to 14 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.48<br/>(0.36 to 0.62) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1151<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies included a mixed STI population, one in children; the other study involved ankle sprains. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>205 per 1000<sup>e</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>98 per 1000<br/>(74 to 127) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurological adverse events</b> </p> <p><i>Follow‐up: 2 hours to 14 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/>(0.30 to 0.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1151<br/>(5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Four studies involved a mixed STI population, one in children; the other study involved ankle sprains. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>203 per 1000<sup>e</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>81 per 1000<br/>(61 to 108) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Early re‐injury</b> (with 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>See Comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No study reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MCID:</b> minimal clinically important difference; <b>RR:</b> risk ratio; <b>STI:</b> soft tissue injury </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty.</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty.</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty.</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty.</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> We downgraded the evidence one level for indirectness, 49% of the evidence and 67% of participants came from one study that used a COX‐2 selective NSAID that has been withdrawn from the market (Valdecoxib)<br/><sup>b</sup> We downgraded the evidence two levels for indirectness, The evidence came from one study that used a COX‐2 selective NSAID that has been withdrawn from the market (Valdecoxib), and also used a suboptimal dose of opioid as a comparator<br/><sup>c</sup> Assumed risk = control risk in this study<br/><sup>d</sup> We downgraded the evidence by two levels for severe study limitations (the sole study reporting this outcome was at high risk of attrition bias relating to incomplete data for this outcome), and one level for imprecision (wide confidence interval)<br/><sup>e</sup>Assumed risk = average control group risk in the studies reporting this outcome<br/><sup>f</sup> We downgraded the evidence one level for indirectness, more than 80% of the evidence and 61% of participants came from one study that used a COX‐2 selective NSAID that has been withdrawn from the market (Valdecoxib) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAID compared with opioid for acute soft tissue injury</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007789-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">NSAID compared with combination (paracetamol and opioid) analgesic for acute soft tissue injury</span></div> <tbody> <tr class="separated"> <th align="left" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>NSAID compared with combination (paracetamol and opioid) analgesic for acute soft tissue injury</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute soft tissue injury, such as ankle sprain<br/><b>Setting:</b> various outpatient locations (e.g. emergency department, GP practice)<br/><b>Intervention:</b> NSAID<br/><b>Comparison:</b> combination (paracetamol plus opioid) analgesic </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with combination (paracetamol and opioid) analgesic</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with NSAID</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Little or no pain at &lt; 24 hours</b> </p> <p><i>Follow‐up: first day</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See Comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study involved ankle or wrist sprain in adults. Just one trial participant, who was in the NSAID group, had little or no pain on the first day. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no pain at 1 to 3 days</b> </p> <p><i>Follow‐up: day 3</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.49<br/>(0.65 to 3.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>149<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study included mixed soft tissue injuries (mainly acute), and the other, ankle and wrist sprain, both in adults. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>108 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1000<br/>(70 to 368) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Little or no pain on day 7 or later</b> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.05<br/>(0.88 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>138<br/>(2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study included mixed soft tissue injuries (mainly acute), and the other, ankle sprain, both in adults. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>671 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>705 per 1000<br/>(591 to 839) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Swelling on day 7 or later</b> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>All three studies presented the means of small categorical scales, so we were unable to present these results in quantitative meta‐analysis. Two (N = 132) reported no significant between‐group differences at three time points (days 3, 5, and 7). One study (N = 98) reported that there was no difference between groups for this outcome on day 7. </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>230<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies included mixed soft tissue injuries, and one ankle sprain. All three were in adults. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Return to function on day 7 or later</b> </p> <p><i>Assessed as 'cure'</i> </p> <p><i>Follow‐up: 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.28<br/>(0.90 to 1.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>89<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>g</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>This study included mixed soft tissue injuries in adults (76% acute)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>523 per 1000<sup>f</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>669 per 1000<br/>(470 to 946) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Gastrointestinal adverse events</b> </p> <p><i>Follow‐up: 3 to 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.21<br/>(0.03 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>141<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study involved ankle sprain, one study involved ankle and wrist sprain, and the third study, mixed soft tissue injuries, all in adults. </p> <p>Just 4 events were reported</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000<br/>(2 to 98) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neurological adverse events</b> </p> <p><i>Follow‐up: 3 to 7 days</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.52<br/>(0.09 to 2.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>141<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>h</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>One study involved ankle sprain, one study involved ankle and wrist sprain, and the third study, mixed soft tissue injuries, all in adults. </p> <p>Just 4 events were reported</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1000<sup>b</sup> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000<br/>(4 to 120) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Early re‐injury</b> (with 3 months) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>See Comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MCID:</b> minimal clinically important difference; <b>RR:</b> risk ratio; <b>STI:</b> soft tissue injury </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty.</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/><b>Moderate certainty.</b> We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/><b>Low certainty.</b> Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect<br/><b>Very low certainty.</b> We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> The available data (one participant experienced little or no pain) for this outcome are too limited to draw any conclusions or useful analysis. Nominally, we downgraded the evidence by one level for study limitations (unclear risk of selection bias and other bias), and two levels for imprecision (very few events, data from one small single study)<br/><sup>b</sup> Assumed risk = average risk for those in combination groups<br/><sup>c</sup> We downgraded the evidence by one level for study limitations (one study was at high risk of bias, reflecting lack of blinding of participants, and one was at unclear risk of selection bias, and other bias), one level for indirectness, since most of the weight of the evidence (87%) came from one study that had suboptimal dosing of both comparators, and two levels for imprecision (few events, wide confidence interval)<br/><sup>d</sup> We downgraded the evidence by one level for study limitations (one study was at high risk of bias, reflecting lack of blinding of participants, and one was at unclear risk of several biases), one level for indirectness, since most of the weight of the evidence (88%) came from one study that had suboptimal dosing of both comparators, and one level for imprecision (wide confidence interval)<br/><sup>e</sup> We downgraded the evidence two levels for risk of bias, as all three studies were either at high or unclear risk of bias across multiple domains, one level for indirectness, due to mixed study populations, and one level for imprecision, due to the small sample size<br/><sup>f</sup> Assumed risk = control group risk in the study reporting this outcome<br/><sup>g</sup> We downgraded the evidence by one level for study limitation (the study was at high risk of bias, relating to lack of participant blinding), two levels for indirectness, reflecting suboptimal dosing of comparators and the inadequate nature of the outcome, and one level for imprecision, due to the small sample size<br/><sup>h</sup> We downgraded the evidence by two levels for study limitations (two studies were at high risk of bias for one or more domains, and the other was at unclear risk of bias for several domains), and two levels for imprecision (very few events, wide confidence interval) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">NSAID compared with combination (paracetamol and opioid) analgesic for acute soft tissue injury</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007789-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of key characteristics of the included trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Condition^</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No. randomised</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No. in analyses (pain)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No. in analyses (at least<br/>1 outcome)</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0001" title="AbbottCJ , Bouchier-HayesTA , HuntHA . A comparison of the efficacy of naproxen sodium and a paracetamol/dextropropoxyphene combination in the treatment of soft-tissue disorders. British Journal of Sports Medicine1980;14(4):213-8. [PMID: 7004556]">Abbott 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (76%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0002" title="AghababianRV . Comparison of diflunisal and acetaminophen with codeine in the management of grade 2 ankle sprain. Clinical Therapeutics1986;8(5):520-6. [MEDLINE: 3094957]">Aghababian 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0003" title="BeveridgeK . Treatment of sports injuries with naproxen sodium and dextropropoxyphene napsylate. Pharmatherapeutica1985;4(6):393-8. [PMID: 2867560]">Beveridge 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0004" title="BondarskyEE , DomingoAT , MatuzaNM , TaylorMB , Thode HC Jr, SingerAJ . Ibuprofen vs acetaminophen vs their combination in the relief of musculoskeletal pain in the ED: a randomized, controlled trial. The American Journal of Emergency Medicine2013;31(9):1357-60. [PMID: 23896011]BondarskyEE , DomingoAT , MatuzaNM , ThodeHC , SingerAJ . Ibuprofen versus acetominophen versus their combination in the relief of musculoskeletal pain in the emergency setting. Annals of Emergency Medicine2011;58 Suppl 4:S255. NCT01827475. Ibuprofen versus acetaminophen vs their combination in the relief of musculoskeletal pain in the emergency setting. clinicaltrials.gov/ct2/show/NCT01827475 (first received 09 April 2013). SingerA . Study results pre-publication [personal communication]. Email to: P Jones 11 December 2012. ">Bondarsky 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (70%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0005" title="BourneM , BentleyS . Enhanced recovery from sports injuries: a comparison of ibuprofen and paracetamol. British Journal of Clinical Practice1980;6(Symp Suppl):72-7. BourneMS . The effect on healing of analgesics and anti-inflammatory therapy. British Journal of Sports Medicine1980;14:26-7. ">Bourne 1980</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0006" title="AlvarezJCB . In children treated in an emergency hospital service for acute traumatic musculoskeletal pain, ibuprofen showed an analgesic efficacy greater than that of paracetamol and codeine [En ninos atendidos en un servicio hospitalario de urgencias por dolor agudo musculoesqueletico de origen traumatico, el ibuprofeno mostro una eficacia analgesica superior a la del paracetamol y la codeina]. Formacion Medica Continuada en Atencion Primaria2007;14(7):439. ClarkE , PlintAC , CorrellR , GabouryI , PassiB . A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma. Pediatrics2007;119(3):460-7. [PMID: 17332198]PlintA . Per-patient adverse events data for acute soft tissue injury patients [personal communication]. Email to: P Jones 25 November 2014. ">Clark 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children: Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol<br/>NSAID vs opioid </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0007" title="CukiernikVA , LimR , WarrenD , SeabrookJA , MatsuiD , RiederMJ . Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Annals of Pharmacotherapy2007;41(9):1368-74. [PMID: 17636113]RiederMJ . Per patient data on adverse events [personal communication]. Email to: P Jones 30 October 2014. ">Cukiernik 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Children: ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0008" title="Dalton JD Jr, SchweinleJE . Randomized controlled noninferiority trial to compare extended release acetaminophen and ibuprofen for the treatment of ankle sprains. Annals of Emergency Medicine2006;48(5):615-23. [PMID: 17052565]NCT00261560. A safety and effectiveness study of acetaminophen extended release (3900 mg/day) and ibuprofen (1200 mg/day) in the treatment of pain associated with ankle sprains. clinicaltrials.gov/ct2/show/NCT00261560 (first received 05 December 2005). ">Dalton 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>260</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0009" title="CawkwellG . Clarification of study data for outcomes in format appropriate for the review [personal communication]. Email to: P Jones 26 August 2008. EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. Effective pain relief with valdecoxib following acute ankle sprain. In: European League Against Rheumatism Annual Congress; 2004 June 9-12; Berlin. Berlin (Germany) http://scientific.sparx-ip.net/archiveeular/?c=a&amp;searchfor=valdecoxib&amp;view=1&amp;item=2004SAT0366, 2004. [SAT0366 (2004)]EkmanEF , RuoffG , KuehlK , RalphL , HormbreyP , FiechtnerJ , et al. The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trial. American Journal of Sports Medicine2006;34(6):945-55. [PMID: 16476920]Pfizer Inc. Multicenter, double-blind, placebo-controlled, randomised, parallel group study to compare the efficacy and tolerability of valdecoxib vs. tramadol in treatment of acute ankle sprains. Protocol 872-IFL-0513-008. www.clinicalstudyresults.org/documents/company-study (accessed 4 August 2008). ">Ekman 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>706</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0010" title="FathiM , ZareMA , BahmaniHR , ZehtabchiS . Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial. American Journal of Emergency Medicine2015;33(9):1205-8. IRCT201112208104N3. Comparison of oxycodone and naproxen in pain control of acute soft tissue injuries. apps.who.int/trialsearch/Trial2.aspx?TrialID=IRCT201112208104N3 (accessed 30 January 2020). ">Fathi 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acute soft tissue injury (&gt;80%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0011" title="GrahamCA , MakPSK , ManSY , WooWK , CattermoleGN , RainerTH . Oral paracetamol or ibuprofen or both for treating pain after soft tissue injuries: double-blind, randomised, controlled trial. In: The Fifth Mediterranean Emergency Medicine Congress; 2009 Sep 14-17; Valencia, Spain. 2009. GrahamCA . Request for study data relevant to this review [personal communication]. Email to: P Jones 15 September 2019. HungKKC , GrahamCA , LoRSL , LeungYK , LeungLY , ManSY , et al. Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: single centre double-blind, randomised controlled clinical trial. PloS One2018;13(2):e0192043. ISRCTN94738550. Cost-effectiveness analysis of oral paracetamol and ibuprofen for treating pain after soft tissue limb injuries: double-blind, randomised controlled trial. apps.who.int/trialsearch/Trial2.aspx?TrialID=ISRCTN94738550 (first received 01 January 2005). [ISRCTN94738550]">Hung 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acute soft tissue injury (86%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>519</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0012" title="IndelicatoPA . Comparison of diflunisal and acetaminophen with codeine in the treatment of mild to moderate pain due to strains and sprains. Clinical Therapeutics1986;8(3):269-74. [PMID: 3521855]">Indelicato 1986</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (and back pain)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0013" title="JafféGV , RoylancePJ , GrimshawJJ . A controlled study of diflunisal in sprains and strains. Current Medical Research and Opinion1978;5(7):584-8. [PMID: 699627]">Jaffé 1978</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle/wrist sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs combined*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0014" title="KayaliC , AgusH , SurerL , TurgutA . The efficacy of paracetamol in the treatment of ankle sprains in comparison with diclofenac sodium. Saudi Medical Journal2007;28(12):1836-9. [PMID: 18060212]KayaliC , AgusH , SurerL . The efficacy of acetaminophen in the treatment of ankle sprains: comparison with diclofenac sodium. Journal of Bone and Joint Surgery. British Volume2009;91(Suppl):163. ">Kayali 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0015" title="GregoireG . Study data relevant to current review (acute soft tissue injury patients) [personal communication]. Email to: P Jones 3 October 2019. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. A randomized controlled trial on oral analgesic utilization for children presenting with a musculoskeletal trauma in the emergency department. Canadian Journal of Emergency Medicine2016;23:S54-5. Le MayS , AliS , PlintA , MasseB , NetoG , AuclairMC , et al. Oral analgesics utilization for children with musculoskeletal injury (OUCH Trial): an RCT. Pediatrics2017;140(5):1-9. ">Le May 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Children: Acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0016" title="LyrtzisC , NatsisK , PapadopoulosC , NoussiosG , PapathanasiouE . Efficacy of paracetamol versus diclofenac for grade II ankle sprains. Foot &amp; Ankle International / American Orthopaedic Foot and Ankle Society [and] Swiss Foot and Ankle Society2011;32(6):571-5. [PMID: 21733417]">Lyrtzis 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0017" title="ManSY , WooWK , LamPKW , RainerTH . Feasibility study comparing oral paracetamol and oral non-steroidal anti-inflammatory drugs for treating pain after musculoskeletal injury: a randomized, double blind, controlled trial. Hong Kong Journal of Emergency Medicine2004;11(2):78-84. ">Man 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (92%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0018" title="McCullochPG , HoldenP , RobsonDJ , RowleyDI , NorrisSH . The value of mobilisation and non-steroidal anti-inflammatory analgesia in the management of inversion injuries of the ankle. British Journal of Clinical Practice1985;39(2):69-72. [PMID: 3872674]McCullochPG . Request for study data that was unavailable [Personal communication]. Email to: P Jones 7 November 2014. ">McCulloch 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ankle sprain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007789-bbs2-0019" title="NL3815 (NTR3982). Paracetamol or NSAID's in minor musculoskeletal trauma. trialregister.nl/trial/3815 (first received 02 May 2013). RidderikhofML , LirkP , GoddijnH , VandewalleE , SchinkelE , Van DierenS , et al. Acetaminophen or nonsteroidal anti-Inflammatory drugs in acute musculoskeletal trauma: a multicenter, double-blind, randomized, clinical trial. Annals of Emergency Medicine2018;71(3):357-68. RidderikhofML , LirkP , SchepNW , HoeberichtsA , GoddijnWT , LuitseJSK , et al. The PanAM study: a multi-center, double-blinded,randomised, non-inferiority study of paracetamol versus non-steroidal anti-inflammatory drugs in treating acute musculoskeletal trauma. BMC Emergency Medicine2013;13(19):1-9. Ridderikhof, ML. Total Adverse Events Data by Study End [personal communication]. Email to: P Jones 29 September 2019. ">Ridderikhof 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acute soft tissue injury (96%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>365</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007789-bbs2-0020" title="RainerTH . Request for study data relevant to this review [personal communication]. Email to: P Jones 25 September 2019. WooWW , ManSY , LamPK , RainerTH . Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal antiinflammatory drugs for treating pain after musculoskeletal injury. Annals of Emergency Medicine2005;46(4):352-61. [PMID: 16187469]">Woo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Acute soft tissue injury (82%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>206</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>TOTAL</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8 = ankle (+ 1 wrist) sprain. Others included any</p> <p>acute soft tissue injury</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>11 'vs paracetamol'<br/>6 'vs opioid'<br/>4 'vs combined' </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3368</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2908</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3287</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>^notes in brackets reflect trials in which a percentage of the population met the review inclusion criteria<br/>*combined = paracetamol plus opioid<br/>vs = versus </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of key characteristics of the included trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/full#CD007789-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007789-tbl-0009"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Level of bias considerable acceptable to include data in the primary meta‐analysis for pain, swelling, function, and adverse effects</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Domain</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Acceptable risk of bias for inclusion in the first order (primary) meta‐analysis</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Sequence generation</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised</p> <p>(Low or unclear risk of bias)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Allocation concealment</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation concealed</p> <p>(Low or unclear)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Blinding</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Critical that participants, care providers, and assessors are blinded to treatment group </p> <p>(Low)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Incomplete outcome data</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≧ 70% follow‐up mandatory for inclusion, providing that reasons for missing data are not related to true outcome, and there is a balance in the number missing from each group </p> <p>(Low)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Selective outcome reporting</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Where there has been selective outcome reporting, the study will be deemed at high risk of bias for that outcome and will be excluded for the meta‐analysis of that outcome </p> <p>(Low)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Other (stopped early, or claimed to be fraudulent)</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(Low or unclear)</p> <p>Note: drug dose differences, length of follow‐up, and characteristics of participants (e.g. age) are specifically excluded from the risk of bias table in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007789-bbs2-0127" title="HigginsJPT , AltmanDG , SterneJAC . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). They are regarded as a potential source of bias, but will be addressed in the analysis by subgroup analysis, and considered in the grading and interpretation of evidence in a 'Summary of findings' table </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Level of bias considerable acceptable to include data in the primary meta‐analysis for pain, swelling, function, and adverse effects</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/information#CD007789-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007789-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs versus paracetamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Pain &lt; 24 hours (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐2.27, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>933</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐2.69, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.40 [‐3.94, 10.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Little or no pain &lt; 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.82, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Pain on days 1 to 3 (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [‐0.91, 3.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐5.16, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.71 [0.83, 8.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>681</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.43 [‐4.59, 3.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Little or no pain on days 1 to 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>894</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.96, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>441</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.93, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>453</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.88, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Pain on days 4 to 6 (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐6.09, 4.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Suboptimal dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐6.09, 4.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Pain on day 7 or later (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [‐0.33, 3.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [‐2.47, 6.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [0.45, 4.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 Suboptimal dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.14 [‐10.30, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Little or no pain on day 7 or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Swelling on days 0 to 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 Suboptimal dose of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Swelling on days 4 to 6 (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 Suboptimal dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Swelling on day 7 or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 Suboptimal dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Little or no swelling on day 7 or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Return to function within 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Return to function in 7 days or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.90, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.94, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.74, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.3 Suboptimal dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Time to return to full activity (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Range of motion (degrees) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Gastrointestinal adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.97, 1.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>754</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.80, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [0.21, 16.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.3 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.13 [1.10, 4.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.4 Suboptimal dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.24, 2.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Neurological adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1679</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.62, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.59, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.2 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>245</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.15, 13.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.3 Suboptimal dosing of paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.18, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.4 Suboptimal dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.25, 106.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs versus paracetamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007789-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NSAID versus opioid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Pain &lt; 24 hours (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1058</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐3.05, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.37 [‐9.17, 2.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Suboptimal dosing of opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐4.41, 3.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐3.16, 5.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Little or no pain &lt; 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Pain on days 4 to 6 (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Suboptimal dosing of opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Pain on day 7 or later (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Suboptimal dosing of opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Swelling on day 7 or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Return to function within 7 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.99, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.16 [0.26, 103.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Suboptimal dosing of opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>642</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.98, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Return to function in 7 days or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>749</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [1.03, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.83, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Suboptimal dosing of opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>686</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [1.02, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Gastrointestinal adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.36, 0.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.39, 1.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.2 Suboptimal dosing of opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.32, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.3 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.13, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Neurological adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.30, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Adequate dosing of both comparators</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.18, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 Suboptimal dosing of opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.30, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.3 Suboptimal dosing of NSAID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 2.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">NSAID versus opioid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007789-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">NSAID versus combination analgesic (paracetamol + opioid)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Little or no pain &lt; 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Little or no pain on days 1 to 3 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.65, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Little or no pain on days 4 to 6 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Little or no pain on day 7 or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.88, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Return to function in 7 days or later <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Gastrointestinal adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.03, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Neurological adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.09, 2.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">NSAID versus combination analgesic (paracetamol + opioid)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007789-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">NSAID versus other oral analgesics</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Pain at &lt; 24 hours (VAS: 0 to 100 mm: worst) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐2.27, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1058</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐3.05, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Gastrointestinal adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.97, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.36, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.3 NSAID vs paracetamol + opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.03, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Neurological adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 NSAID vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1679</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.62, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 NSAID vs opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1151</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.30, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.3 NSAID vs paracetamol + opioid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.09, 2.84]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">NSAID versus other oral analgesics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007789.pub3/references#CD007789-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007789.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007789-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007789-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007789-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007789-note-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ko#CD007789-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD007789-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD007789-note-0007">Português</a> </li> <li class="section-language"> <a class="" href="th#CD007789-note-0008">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007789\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007789\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007789\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007789\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007789\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007789.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007789.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007789.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007789.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007789.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714786297"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007789.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714786300"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007789.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d772c7d74937d',t:'MTc0MDcxNDc4Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 